Hillenbrand (HI) 10-Q 4 Aug 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Jun. 30, 2021	Apr. 29, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	001-33794
Entity Registrant Name	HILLENBRAND, INC.
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	26-1342272
Entity Address, Address Line One	One Batesville Boulevard
Entity Address, City or Town	Batesville
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	47006
City Area Code	812
Local Phone Number	934-7500
Title of 12(b) Security	Common Stock, without par value
Trading Symbol	HI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		73,038,372
Entity Central Index Key	0001417398
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Net revenue	$ 695.1	$ 607.5	$ 2,109.9	$ 1,823.3
Cost of goods sold	469.2	400.2	1,393.9	1,250.5
Gross profit	225.9	207.3	716	572.8
Operating expenses	126.6	118.5	396.2	411.9
Amortization expense	14.1	16.4	41.8	55.2
Gain (Loss) on Disposition of Business	(0.1)	0	(65.8)	3
Impairment charges	0	0	0	82.5
Interest expense	19	19.7	59.7	55.3
Other (expense) income, net	(0.4)	0.6	0.2	4.8
Income (loss) before income taxes	65.9	53.3	284.3	(30.3)
Income tax expense	24.4	28.3	86.1	17.7
Consolidated net income (loss)	41.5	25	198.2	(48)
Less: Net income attributable to noncontrolling interests	1.1	1	3.3	5.1
Net income (loss)	$ 40.4	$ 24	$ 194.9	$ (53.1)
Net income (loss) attributable to Hillenbrand — per share of common stock:
Basic earnings (loss) per share	$ 0.54	$ 0.32	$ 2.59	$ (0.73)
Diluted earnings (loss) per share	$ 0.53	$ 0.32	$ 2.57	$ (0.73)
Weighted average shares outstanding (basic)	75.5	75.1	75.4	72.8
Weighted average shares outstanding (diluted)	76.2	75.1	75.9	72.8

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Statement of Comprehensive Income [Abstract]
Consolidated net income (loss)	$ 41.5	$ 25	$ 198.2	$ (48)
Changes in other comprehensive income, net of tax:
Currency translation adjustment	29.2	11.9	43.3	(1)
Pension and postretirement (net of quarter-to-date tax expense of $0.4 and $0.4 and year-to-date tax expense of $1.0 and $1.3)	0.9	1.3	2.7	3.8
Change in net unrealized gain on derivative instruments (net of quarter-to-date tax (benefit) expense of ($0.1) and $0.9 and year-to-date tax (benefit) expense of ($0.1) and $0.7)	0.3	2.4	1.5	0.5
Total changes in other comprehensive income, net of tax	30.4	15.6	47.5	3.3
Consolidated comprehensive income (loss)	71.9	40.6	245.7	(44.7)
Less: Comprehensive income attributable to noncontrolling interests	0.9	0.9	3.2	4.4
Comprehensive income (loss)	$ 71	$ 39.7	$ 242.5	$ (49.1)

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Statement of Comprehensive Income [Abstract]
Pension and postretirement, tax	$ (0.4)	$ (0.1)	$ (0.9)	$ (0.2)
Change in net unrealized gain (loss) on derivative instruments, tax	$ 0.8	$ 0.9	$ 0.6	$ 2.6

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Current Assets
Cash and cash equivalents	$ 476.2	$ 302.2
Trade receivables, net	293.6	279.5
Receivables from long-term manufacturing contracts	124.2	138.1
Inventories, net	410.9	385.4
Prepaid expenses and other current assets	75.1	83.2
Current assets held for sale	61.4	181.3
Total current assets	1,441.4	1,369.7
Property, plant, and equipment, net	294.4	314.2
Operating lease right-of-use assets, net	146.3	154.4
Intangible assets, net	931.2	960.7
Goodwill	1,175.8	1,137.8
Other long-term assets	48.3	50.6
Total Assets	4,037.4	3,987.4
Current Liabilities
Trade accounts payable	329.3	271.6
Liabilities from long-term manufacturing contracts and advances	324.9	189.1
Current portion of long-term debt	0	36.3
Accrued compensation	105.6	96.1
Current liabilities held for sale	19.2	32.5
Other current liabilities	244	226.5
Total current liabilities	1,023	852.1
Long-term debt	1,212.4	1,516.3
Accrued pension and postretirement healthcare	164.2	166.8
Operating lease liabilities	112.8	120.9
Deferred income taxes	200.8	185.8
Other long-term liabilities	71.8	66.1
Total Liabilities	2,785	2,908
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY
Common stock, no par value (75.8 and 75.8 shares issued, 74.3 and 74.8 shares outstanding)	0	0
Additional paid-in capital	722.9	723.6
Retained earnings	627.1	481.4
Treasury stock (1.5 and 1.0 shares, at cost)	(64.6)	(43.2)
Accumulated other comprehensive loss	(55.2)	(102.8)
Hillenbrand Shareholders’ Equity	1,230.2	1,059
Noncontrolling interests	22.2	20.4
Total Shareholders’ Equity	1,252.4	1,079.4
Total Liabilities and Shareholders’ Equity	$ 4,037.4	$ 3,987.4

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2021	Sep. 30, 2020
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)
Common stock, shares issued	75,800,000	63,900,000
Common stock, shares outstanding	74,700,000	62,300,000
Treasury stock, shares	1,100,000	1,600,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flow - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Operating Activities
Consolidated net income (loss)	$ 198,200	$ (48,000)
Adjustments to reconcile consolidated net income (loss) to cash provided by operating activities:
Depreciation and amortization	86,300	98,400
Impairment charges	0	82,500
Deferred income taxes	13,600	(23,400)
Amortization of deferred financing costs	6,200	2,500
Share-based compensation	14,700	9,400
Settlement of Milacron share-based equity awards	0	(5,900)
Net loss on divestiture	(65,800)	3,000
Trade accounts receivable, net and receivables from long-term manufacturing contracts	10,200	59,600
Inventories, net	(30,600)	35,900
Prepaid expenses and other current assets	3,400	6,500
Trade accounts payable	54,700	(76,400)
accrued compensation, and other current liabilities	147,300	(46,700)
Income taxes payable	4,100	15,500
Defined benefit plan and postretirement funding	(6,800)	(7,500)
Defined benefit plan and postretirement expense	2,100	4,600
Other, net	5,100	(1,700)
Net cash provided by operating activities	442,700	120,100
Acquisition of businesses, net of cash acquired	0	(1,503,100)
Investing Activities
Capital expenditures	(21,800)	(20,300)
Proceeds from divestitures, net of cash divested		222,400
Proceeds from sales of property, plant, and equipment	100	14,200
Net cash provided by (used in) investing activities	144,100	(1,286,800)
Financing Activities
Proceeds from issuance of long-term debt	350,000	1,125,200
Repayments on long-term debt	(688,800)	(27,200)
Proceeds from revolving credit facilities	395,000	1,157,800
Repayments on revolving credit facilities	(395,000)	(1,158,900)
Payment of deferred financing costs	(5,400)	(13,700)
Payments of dividends on common stock	(48,400)	(47,600)
Repurchases of common stock	(43,400)	0
Proceeds from stock option exercises	9,200	400
Payments for employee taxes on net settlement equity awards	(3,500)	(1,900)
Other, net	(1,300)	(3,000)
Net cash (used in) provided by financing activities	(431,600)	1,031,100
Effect of exchange rates on cash and cash equivalents	10,700	1,100
Net cash flows	165,900	(134,500)
Cash, cash equivalents, and restricted cash:
At beginning of period	311,800	399,400
At end of period	$ 477,700	$ 264,900

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flow Cash, Cash Equivalents, and Restricted Cash - USD ($) $ in Millions	Jun. 30, 2021	Jun. 14, 2021	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019
Supplemental Cash Flow Elements [Abstract]
Cash and cash equivalents	$ 476.2		$ 302.2	$ 263.1
Restricted Cash and Cash Equivalents	1.5			1.8
Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows	$ 477.7	$ 350	$ 311.8	$ 264.9	$ 399.4

Consolidated Statements of Shar

Consolidated Statements of Shareholders Equity Statement - USD ($) shares in Millions, $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Retained Earnings [Member]Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	AOCI Attributable to Parent [Member]	AOCI Attributable to Parent [Member]Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling Interests
Balance at Sep. 30, 2019	$ 769.8	$ 0		$ 345.3	$ 599.5	$ 6	$ (50.1)	$ (140.6)	$ (6)	$ 15.7
Balance, shares at Sep. 30, 2019			63.9				1.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total other comprehensive income (loss), net of tax	3.3							4		(0.7)
Consolidated net income (loss)	(48)				(53.1)					5.1
Common stock, shares issued							0.1
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture	(1.5)			(6.7)			$ 5.2
Share-based compensation	9.4			9.4
Dividends, Common Stock	(49.2)			0.4	(48)					(1.6)
Common stock issued to acquire Milacron (in shares)			11.9
Common stock issued to acquire Milacron (see Note 4)	371.3			371.3
Balance at Jun. 30, 2020	$ 1,055.1			719.7	504.4		$ (44.9)	(142.6)		18.5
Balance, shares at Jun. 30, 2020			75.8				1.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.4200
Balance at Mar. 31, 2020	$ 1,027			716.3	496.4		$ (45.4)	(158.3)		18
Balance, shares at Mar. 31, 2020			75.8				1.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total other comprehensive income (loss), net of tax	15.6							15.7		(0.1)
Consolidated net income (loss)	25				24					1
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture	0.1			(0.4)			$ 0.5
Share-based compensation	3.7			3.7
Dividends, Common Stock	(16.3)			0.1	(16)					(0.4)
Balance at Jun. 30, 2020	$ 1,055.1			719.7	504.4		$ (44.9)	(142.6)		18.5
Balance, shares at Jun. 30, 2020			75.8				1.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.2100
Balance at Sep. 30, 2020	$ 1,079.4			723.6	481.4		$ (43.2)	(102.8)		20.4
Balance, shares at Sep. 30, 2020			75.8				1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total other comprehensive income (loss), net of tax	47.5							47.6		(0.1)
Consolidated net income (loss)	198.2				194.9					3.3
Stock Repurchased During Period, Value	$ 43.4
Stock Repurchased During Period, Shares	1
Common stock, shares issued							(0.5)
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture	$ 5.8			(16.2)			$ 22
Share-based compensation	14.7			14.7
Dividends, Common Stock	(49.8)			0.8	(49.2)					(1.4)
Balance at Jun. 30, 2021	$ 1,252.4			722.9	627.1		$ (64.6)	(55.2)		22.2
Balance, shares at Jun. 30, 2021			75.8				1.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.4250
Balance at Mar. 31, 2021	$ 1,235.7			720.5	603.1		$ (23.4)	(85.8)		21.3
Balance, shares at Mar. 31, 2021			75.8				0.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total other comprehensive income (loss), net of tax	30.4							30.6		(0.2)
Consolidated net income (loss)	41.5				40.4					1.1
Stock Repurchased During Period, Value	$ (43.4)
Stock Repurchased During Period, Shares	1
Common stock, shares issued							(0.1)
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture	$ 0			(2.2)			$ 2.2
Share-based compensation	4.3			4.3
Dividends, Common Stock	(16.1)			0.3	(16.4)
Balance at Jun. 30, 2021	$ 1,252.4			$ 722.9	$ 627.1		$ (64.6)	$ (55.2)		$ 22.2
Balance, shares at Jun. 30, 2021			75.8				1.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.2125

Background and Basis of Present

Background and Basis of Presentation	9 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Hillenbrand, Inc. (the “Company” or “Hillenbrand”) is a global diversified industrial company with multiple leading brands that serve a wide variety of industries around the world. The Company strives to provide superior return for our shareholders, exceptional value for our customers, great professional opportunities for our employees, and to be responsible to our communities through deployment of the Hillenbrand Operating Model (“HOM”). The HOM is a consistent and repeatable framework designed to produce sustainable and predictable results. The HOM describes the Company’s mission, vision, values, and mindset as leaders; applies our management practices in Strategy Management, Segmentation, Lean, Talent Development, and Acquisitions; and prescribes three steps (Understand, Focus, and Grow) designed to make the Company’s businesses both bigger and better. The Company’s goal is to continue developing Hillenbrand as a world-class global diversified industrial company through the deployment of the HOM. Hillenbrand’s portfolio is composed of three reportable operating segments. Advanced Process Solutions operating companies design, develop, manufacture, and service highly engineered industrial equipment around the world. Molding Technology Solutions is a global leader in highly engineered and customized systems in plastic technology and processing. Batesville is a recognized leader in the death care industry in North America. “Hillenbrand,” the “Company,” “we,” “us,” “our,” and similar words refer to Hillenbrand and its subsidiaries unless context otherwise requires. The accompanying unaudited Consolidated Financial Statements include the accounts of Hillenbrand and its subsidiaries. They also include two subsidiaries where the Company’s ownership percentage is less than 100%. The Company’s fiscal year ends on September 30. Unless otherwise stated, references to years relate to fiscal years. These unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements and therefore do not include all information required in accordance with United States generally accepted accounting principles (“GAAP”). The unaudited Consolidated Financial Statements have been prepared on the same basis as, and should be read in conjunction with, the audited Consolidated Financial Statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended September 30, 2020, as filed with the SEC on November 12, 2020. In the opinion of management, these Consolidated Financial Statements reflect all adjustments necessary to present a fair statement of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented and are normal and recurring in nature. The interim period results are subject to variation and are not necessarily indicative of the results of operations to be expected for the full fiscal year. The preparation of the Consolidated Financial Statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. Examples of such estimates include, but are not limited to, revenue recognition under the percentage-of-completion method, carrying value of businesses held for sale, and the establishment of reserves related to customer rebates, doubtful accounts, warranties, early-pay discounts, inventories, income taxes, litigation, self-insurance, and progress toward achievement of performance criteria under incentive compensation programs. On March 11, 2020, the World Health Organization declared the outbreak of the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide, and the effects of the COVID-19 pandemic and such associated measures on management’s estimates and results of operations through June 30, 2021 are reflected in the Consolidated Financial Statements. Given the unprecedented nature of the COVID-19 pandemic, the Company cannot reasonably estimate the full extent of the impact that the COVID-19 pandemic will continue to have on its consolidated financial condition, results of operations, or cash flows in the foreseeable future. The ultimate impact of the COVID-19 pandemic on the Company is highly uncertain and will depend on future developments, and such impacts could exist for an extended period of time, even after the COVID-19 pandemic subsides or if variant strains of the virus further impact the global economy or the Company. Events and changes in circumstances arising after June 30, 2021, including those resulting from the ongoing impacts of the COVID-19 pandemic, will be reflected in management’s estimates for future periods in subsequent periodic filings.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies The significant accounting policies used in preparing the Consolidated Financial Statements are consistent with the accounting policies described in the Company’s Annual Report on Form 10-K as of and for the year ended September 30, 2020, except as described below. Recently Adopted Accounting Standards In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 replaces the current incurred loss impairment model with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to determine credit loss estimates. ASU 2016-13 became effective for the Company’s fiscal year beginning on October 1, 2020. As a result of the Company’s assessment on its trade receivables and receivables from long-term manufacturing contracts, ASU 2016-13 did not have a material impact on the Consolidated Financial Statements. In February 2018, the FASB issued ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (“ASU 2018-02”). ASU 2018-02 allows for the reclassification of stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) from accumulated other comprehensive loss to retained earnings. The Company adopted ASU 2018-02 on October 1, 2019, which resulted in a one-time decrease to accumulated other comprehensive loss and an increase to retained earnings of $6.0 on the Consolidated Balance Sheet as of October 1, 2019, primarily related to deferred taxes previously recorded for pension and other postretirement benefits. The adoption of ASU 2018-02 did not have an impact to the Consolidated Statements of Operations or Consolidated Statements of Cash Flows. Recently Issued Accounting Standards In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 clarifies and simplifies accounting for income taxes by eliminating certain exceptions for intraperiod tax allocation principles, the methodology for calculating income tax rates in an interim period, and recognition of deferred taxes for outside basis differences in an investment, among other updates. ASU 2019-12 will be effective for the Company’s fiscal year beginning on October 1, 2021. The Company is currently evaluating the impact of ASU 2019-12 on the Consolidated Financial Statements. No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Net revenue includes gross revenue less sales discounts, customer rebates, sales incentives, and product returns, all of which require the Company to make estimates for the portion of these allowances that have yet to be credited or paid to customers. The Company estimates these allowances using the expected value method, which is based upon historical rates and projections of customer purchases toward contractual rebate thresholds. Contract balances The balance in receivables from long-term manufacturing contracts at June 30, 2021 and September 30, 2020 was $124.2 and $138.1, respectively. The change was driven by the impact of net revenue recognized prior to billings. The balance in the liabilities from long-term manufacturing contracts and advances at June 30, 2021 and September 30, 2020 was $324.9 and $189.1, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The revenue recognized for the nine months ended June 30, 2021 and 2020 related to liabilities from long-term manufacturing contracts and advances as of September 30, 2020 and 2019 was $128.8 and $104.7, respectively. During the three and nine months ended June 30, 2021 and 2020, the adjustments related to performance obligations satisfied in previous periods were immaterial. Transaction price allocated to the remaining performance obligations As of June 30, 2021, the aggregate amount of transaction price of remaining performance obligations for the Company, which corresponds to backlog as defined in Item 2 of this Form 10-Q, was $1,765.9. Approximately 76% of these performance obligations are expected to be satisfied over the next twelve months, and the remaining performance obligations, primarily within one to three years. Disaggregation of revenue The following tables present net revenue by end market: Three Months Ended June 30, 2021 Nine Months Ended June 30, 2021 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total End Market Plastics $ 225.8 $ — $ — $ 225.8 $ 630.9 $ — $ — $ 630.9 Automotive — 44.9 — 44.9 — 123.9 — 123.9 Chemicals 21.8 — — 21.8 61.1 — — 61.1 Consumer goods — 22.4 — 22.4 — 69.0 — 69.0 Food and pharmaceuticals 21.5 — — 21.5 65.1 — — 65.1 Custom molders — 28.8 — 28.8 — 110.2 — 110.2 Packaging — 29.6 — 29.6 — 95.7 — 95.7 Construction — 32.2 — 32.2 — 84.4 — 84.4 Minerals and mining 13.7 — — 13.7 38.0 — — 38.0 Electronics — 21.6 — 21.6 — 55.3 — 55.3 Medical — 23.1 — 23.1 — 65.3 — 65.3 Death care — — 137.9 137.9 — — 468.7 468.7 Other industrial 30.6 41.2 — 71.8 110.4 131.9 — 242.3 Total $ 313.4 $ 243.8 $ 137.9 $ 695.1 $ 905.5 $ 735.7 $ 468.7 $ 2,109.9 Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total End Market Plastics $ 181.0 $ — $ — $ 181.0 $ 589.6 $ — $ — $ 589.6 Automotive — 28.7 — 28.7 — 91.8 — 91.8 Chemicals 21.5 — — 21.5 69.9 — — 69.9 Consumer goods — 25.4 — 25.4 — 76.6 — 76.6 Food and pharmaceuticals 19.7 — — 19.7 54.9 — — 54.9 Custom molders — 28.4 — 28.4 — 66.5 — 66.5 Packaging — 23.8 — 23.8 — 60.5 — 60.5 Construction — 20.0 — 20.0 — 51.8 — 51.8 Minerals and mining 15.0 — — 15.0 43.7 — — 43.7 Electronics — 20.3 — 20.3 — 43.1 — 43.1 Medical — 20.4 — 20.4 — 39.7 — 39.7 Death care — — 139.9 139.9 — — 405.7 405.7 Other industrial 44.1 19.3 — 63.4 140.9 88.6 — 229.5 Total $ 281.3 $ 186.3 $ 139.9 $ 607.5 $ 899.0 $ 518.6 $ 405.7 $ 1,823.3 The following tables present net revenue by geographical market: Three Months Ended June 30, 2021 Nine Months Ended June 30, 2021 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Geographical Markets Americas $ 76.5 $ 127.9 $ 137.9 $ 342.3 $ 240.2 $ 391.4 $ 468.7 $ 1,100.3 Asia 149.1 74.0 — 223.1 411.9 218.1 — 630.0 Europe, the Middle East, and Africa 87.8 41.9 — 129.7 253.4 126.2 — 379.6 Total $ 313.4 $ 243.8 $ 137.9 $ 695.1 $ 905.5 $ 735.7 $ 468.7 $ 2,109.9 Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Geographical Markets Americas $ 93.1 $ 105.0 $ 139.9 $ 338.0 $ 306.6 $ 290.4 $ 405.7 $ 1,002.7 Asia 121.9 50.9 — 172.8 349.5 133.6 — 483.1 Europe, the Middle East, and Africa 66.3 30.4 — 96.7 242.9 94.6 — 337.5 Total $ 281.3 $ 186.3 $ 139.9 $ 607.5 $ 899.0 $ 518.6 $ 405.7 $ 1,823.3 The following tables present net revenue by products and services: Three Months Ended June 30, 2021 Nine Months Ended June 30, 2021 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Products and Services Equipment $ 219.6 $ 163.2 $ — $ 382.8 $ 621.1 $ 487.6 $ — $ 1,108.7 Parts and services 93.8 64.1 — 157.9 284.4 197.6 — 482.0 Death care — — 137.9 137.9 — — 468.7 468.7 Other — 16.5 — 16.5 — 50.5 — 50.5 Total $ 313.4 $ 243.8 $ 137.9 $ 695.1 $ 905.5 $ 735.7 $ 468.7 $ 2,109.9 Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Products and Services Equipment $ 186.7 $ 124.7 $ — $ 311.4 $ 600.6 $ 305.8 $ — $ 906.4 Parts and services 94.6 49.2 — 143.8 298.4 139.7 — 438.1 Death care — — 139.9 139.9 — — 405.7 405.7 Other — 12.4 — 12.4 — 73.1 — 73.1 Total $ 281.3 $ 186.3 $ 139.9 $ 607.5 $ 899.0 $ 518.6 $ 405.7 $ 1,823.3 The following tables present net revenue by timing of transfer: Three Months Ended June 30, 2021 Nine Months Ended June 30, 2021 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Timing of Transfer Point in time $ 153.9 $ 242.6 $ 137.9 $ 534.4 $ 450.3 $ 734.5 $ 468.7 $ 1,653.5 Over time 159.5 1.2 — 160.7 455.2 1.2 — 456.4 Total $ 313.4 $ 243.8 $ 137.9 $ 695.1 $ 905.5 $ 735.7 $ 468.7 $ 2,109.9

Business Acquisitions and Dives

Business Acquisitions and Divestitures	9 Months Ended
	Jun. 30, 2021
Business Combinations [Abstract]
Business Acquisitions	Acquisitions and Divestitures Acquisition of Milacron Background On November 21, 2019, the Company completed the acquisition of Milacron Holdings Corp. (“Milacron”), a global leader in highly engineered and customized systems in plastic technology and processing, through a merger of its wholly-owned subsidiary with and into Milacron, resulting in ownership of 100% of Milacron common stock that was issued and outstanding after the acquisition. The acquisition provides Hillenbrand with increased scale and meaningful product diversification, enhancing its ability to serve customers with expanded capabilities across the plastics value chain. The results of Milacron are reported separately in its own reportable operating segment (Molding Technology Solutions). Purchase price consideration As a result of the acquisition, Milacron stockholders received $11.80 in cash per share and a fixed exchange ratio of 0.1612 shares of Hillenbrand common stock for each share of Milacron common stock they owned, with cash paid in lieu of fractional shares. In addition, concurrent with the closing of the acquisition, the Company made a cash payment of $772.9 to repay outstanding Milacron debt, including accrued interest. The Company funded the acquisition through a combination of cash on hand, new debt financing, and the issuance of common stock. Pursuant to the Merger Agreement, certain of Milacron’s outstanding stock options, restricted stock awards, restricted stock unit awards, and performance stock unit awards immediately vested and converted into the right to receive $11.80 per share in cash and 0.1612 shares of Hillenbrand common stock per share. Additionally, certain of Milacron’s stock appreciation rights were canceled and converted into the right to receive a lump sum cash payment. The fair value of share-based equity awards was apportioned between purchase price consideration and immediate expense. The portion of the fair value of partially vested awards associated with pre-acquisition service of Milacron employees represented a component of the total purchase price consideration, while the remaining portion of the fair value was immediately recognized as expense within operating expenses on the Consolidated Statement of Operations during the nine months ended June 30, 2020. The following table summarizes the aggregate purchase price consideration to acquire Milacron: Cash consideration paid to Milacron stockholders $ 835.9 Repayment of Milacron debt, including accrued interest 772.9 Cash consideration paid to settle outstanding share-based equity awards 34.2 Total cash consideration 1,643.0 Fair value of Hillenbrand common stock issued to Milacron stockholders (1) 356.9 Stock consideration issued to settle outstanding share-based equity awards (1) 14.4 Total consideration transferred 2,014.3 Portion of cash settlement of outstanding share-based equity awards recognized as expense (2) (14.1) Portion of stock settlement of outstanding share-based equity awards recognized as expense (2) (5.9) Total purchase price consideration $ 1,994.3 (1) The fair value of the 11.4 million shares of Hillenbrand’s common stock issued as of the acquisition date was determined based on a per share price of $31.26, which was the closing price of Hillenbrand’s common stock on November 20, 2019, the last trading day before the acquisition closed on November 21, 2019. This includes a nominal amount of cash paid in lieu of fractional shares. Additionally, 0.5 million shares of Hillenbrand’s common stock were issued to settle certain of Milacron’s outstanding share-based equity awards, as previously discussed. (2) In total, $20.0 was immediately recognized as expense within operating expenses on the Consolidated Statements of Operations during the nine months ended June 30, 2020, which represents the portion of the fair value of outstanding share-based equity awards that was not associated with pre-acquisition service of Milacron employees, as previously discussed. Purchase price allocation The acquisition was accounted for as a business combination in accordance with Accounting Standards Codification (“ASC”) Topic 805, Business Combinations . The purchase price was allocated to the assets acquired and liabilities assumed based on management’s estimate of the respective fair values at the date of acquisition. Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The factors contributing to the recognition of goodwill were based on strategic benefits that are expected to be realized from the acquisition. None of the goodwill is deductible for income tax purposes. The following table summarizes the final (as of November 21, 2020) fair values of the assets acquired and liabilities assumed as of the acquisition date (November 21, 2019). Assets acquired: Cash and cash equivalents $ 125.8 Trade receivables 133.1 Inventories 287.7 Prepaid expense and other current assets 69.2 Property, plant, and equipment 233.9 Operating lease right-of-use assets 41.3 Identifiable intangible assets 815.0 Goodwill 734.2 Other long-term assets 21.0 Total assets acquired 2,461.2 Liabilities assumed: Trade accounts payable 110.2 Liabilities from long-term manufacturing contracts and advances 32.7 Accrued compensation 20.8 Other current liabilities 89.4 Accrued pension and postretirement healthcare 29.4 Deferred income taxes 139.0 Operating lease liabilities - long-term 31.2 Other long-term liabilities 14.2 Total liabilities assumed 466.9 Total purchase price consideration $ 1,994.3 Intangible assets identified The purchase price allocation included $815.0 of acquired identifiable intangible assets. The fair value of the identifiable intangible assets were estimated using the income approach through a discounted cash flow analysis with cash flow projections. The cash flows were based on estimates used to price the Milacron acquisition, and the discount rates applied were benchmarked with reference to the implied rate of return to the Company’s pricing model and the weighted-average cost of capital. Definite-lived intangible assets are being amortized over the estimated useful life on a straight-line basis. The determination of the useful lives was based upon various industry studies, historical acquisition experience, economic factors, and future cash flows of the Company post-acquisition of Milacron. In addition, Hillenbrand reviewed certain technological trends and considered the relative stability in the current Milacron customer base. The amounts allocated to intangible assets are as follows: Gross Carrying Amount Weighted-Average Useful Life Customer relationships $ 560.0 19 years Trade names 150.0 Indefinite Technology, including patents 95.0 10 years Backlog 10.0 3 months Total $ 815.0 The Company is required to provide additional disclosures about fair value measurements as part of the Consolidated Financial Statements for each major category of assets and liabilities measured at fair value on a nonrecurring basis (including business acquisitions). The working capital assets and liabilities, as well as the property, plant, and equipment acquired, were valued using Level 2 inputs which included data points that are observable, such as definitive sales agreements, appraisals or established market values of comparable assets (market approach). Goodwill and identifiable intangible assets were valued using Level 3 inputs, which are unobservable by nature, and included internal estimates of future cash flows (income approach). Significant increases (decreases) in any of those unobservable inputs, as of the date of the acquisition, in isolation would result in a significantly lower (higher) fair value measurement. Management used a third-party valuation firm to assist in the determination of the purchase accounting fair values, and specifically those considered Level 3 measurements. Management ultimately oversaw the third-party valuation firm to ensure that the transaction-specific assumptions are appropriate for the Company. Impact on results of operations The results of Milacron’s operations have been included in Hillenbrand’s Consolidated Financial Statements since the November 21, 2019 acquisition date, within the Molding Technology Solutions reportable operating segment. The following table provides the results of operations for Milacron included in Hillenbrand’s Consolidated Statements of Operations. Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Net revenue $ 243.8 $ 186.3 $ 735.7 $ 518.6 Income (loss) before income taxes 30.9 12.0 93.3 (17.5) In connection with the acquisition of Milacron, the Company incurred a total of $5.1 and $17.4 and $5.0 and $62.7 of business acquisition and integration costs during the three and nine months ended June 30, 2021 and 2020, respectively, which were recorded within operating expenses in the Consolidated Statements of Operations. Supplemental Pro Forma Information The supplemental pro forma financial information presented below is for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the Milacron acquisition had been completed on the date indicated, does not reflect synergies that might have been achieved, nor is it indicative of future operating results or financial position. The pro forma adjustments are based upon currently available information and certain assumptions that Hillenbrand believes are reasonable under the circumstances. The supplemental pro forma financial information reflects pro forma adjustments to present the combined pro forma results of operations as if the Milacron acquisition had occurred on October 1, 2019, to give effect to certain events that Hillenbrand believes to be directly attributable to the Milacron acquisition. These pro forma adjustments primarily include: • an increase to depreciation and amortization expense that would have been recognized due to acquired tangible and intangible assets; • an adjustment to interest expense to reflect the additional borrowings of Hillenbrand and the repayment of Milacron’s historical debt in conjunction with the acquisition; • an adjustment to remove business acquisition and integration costs, inventory step-up costs, and backlog amortization as these costs are non-recurring in nature and will not have a continuing effect on Hillenbrand’s results; and • the related income tax effects of the adjustments noted above. The supplemental pro forma financial information for the periods presented is as follows: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net revenue $ 695.1 $ 607.5 $ 2,109.9 $ 1,939.0 Net income (loss) attributable to Hillenbrand 40.4 30.4 194.9 (0.7) Net income (loss) attributable to Hillenbrand — per share of common stock: Basic earnings (loss) per share $ 0.54 $ 0.40 $ 2.59 $ (0.01) Diluted earnings (loss) per share $ 0.53 $ 0.40 $ 2.57 $ (0.01) Assets and liabilities held for sale During the fourth quarter of 2020, the Company announced that it had initiated a plan to divest the TerraSource Global and flow control businesses, which includes the Red Valve business (“Red Valve”) and Abel Pump business (“ABEL”), which operated within the Advanced Process Solutions reportable operating segment, as these businesses were no longer considered a strategic fit with the Company’s long-term growth plan and operational objectives. As discussed below, the Company completed the sale of Red Valve on December 31, 2020, and ABEL on March 10, 2021. The Company still intends to divest the TerraSource Global business in the near term. As of September 30, 2020, the Company determined that these businesses met the criteria to be classified as held for sale, and therefore reclassified the related assets and liabilities as held for sale on the Consolidated Balance Sheets. As of June 30, 2021, the TerraSource Global business continues to be classified as held for sale. The following is a summary of the major categories of assets and liabilities that have been classified as held for sale on the Consolidated Balance Sheets: June 30, September 30, Trade receivables, net $ 6.3 $ 19.8 Inventories 12.5 22.0 Property, plant and equipment, net (1) 12.1 18.1 Operating lease right-of-use assets, net 2.0 4.3 Intangible assets, net 49.5 133.6 Goodwill 12.4 19.5 Other assets 2.5 9.4 Valuation allowance on disposal group (2) (35.9) (45.4) Total assets held for sale $ 61.4 $ 181.3 Trade accounts payable $ 4.0 $ 7.3 Liabilities from long-term manufacturing contracts and advances 5.9 4.9 Operating lease liabilities 2.2 4.5 Deferred income taxes 5.0 8.8 Other liabilities 2.1 7.0 Total liabilities held for sale $ 19.2 $ 32.5 (1) Total assets held for sale in this table include certain parcels of real estate that are also classified as held for sale on the Company’s Consolidated Balance Sheets as of June 30, 2021 and September 30, 2020. (2) The Company adjusted the carrying value to fair value less costs to sell for certain assets held for sale during the year ended September 30, 2020. There was no adjustment recognized for the three and nine months ended June 30, 2021. The Company determined that the exit from these businesses does not represent a strategic shift that had or will have a major effect on its Consolidated Results of Operations, and therefore these businesses were not classified as discontinued operations. The results of operations up to the respective dates of sale for these businesses are included within the Advanced Process Solutions reportable operating segment for all periods presented in this quarterly report. Divestiture of Flow Control Businesses On December 31, 2020, the Company completed the divestiture of Red Valve to DeZURIK, Inc. in a transaction valued at $63.0. The sale included cash proceeds received at closing of $59.4, including working capital adjustments, and a $5.0 note receivable, included within other long-term assets on the Consolidated Balance Sheet. The sale follows the Company’s previously announced intent to exit Red Valve, and Red Valve was classified as held for sale at September 30, 2020. As a result of the Red Valve sale, the Company recorded a pre-tax gain of $31.6 in the Consolidated Statement of Operations during the nine months ended June 30, 2021. The related tax effect resulted in tax expense of $3.8 and was included within income tax expense in the Consolidated Statement of Operations during the nine months ended June 30, 2021. The Company incurred $2.9 of transaction costs associated with the sale during the nine months ended June 30, 2021, which were recorded within operating expenses in the Consolidated Statement of Operations. On March 10, 2021, the Company completed the divestiture of ABEL to IDEX Corporation, in a transaction valued at $103.5, subject to customary post-closing adjustments. The sale included cash proceeds received at closing of $106.3, including working capital adjustments. The sale follows the Company's previously announced intent to exit ABEL, and ABEL was classified as held for sale at September 30, 2020. As a result of the ABEL sale, the Company recorded a pre-tax gain after post-closing adjustments of $34.2 in the Consolidated Statement of Operations during the nine months ended June 30, 2021. The related tax effect resulted in tax expense of $6.9 and was included within income tax expense in the Consolidated Statement of Operations during the nine months ended June 30, 2021. The Company incurred $3.9 of transaction costs associated with the sale during the nine months ended June 30, 2021, which were recorded within operating expenses in the Consolidated Statement of Operations. Divestiture of Cimcool On March 30, 2020, the Company completed the sale of its Cimcool business (“Cimcool”), which represented the former Fluids Technologies reportable segment of Milacron before its acquisition by the Company, to DuBois Chemicals, Inc. The sale resulted in cash proceeds received of $222.4, net of cash divested. As a result of the Cimcool sale, the Company recorded a pre-tax loss of $3.0, using Level 2 nonrecurring fair value measurements, within other (expense) income, net in the Consolidated Statement of Operations during the nine months ended June 30, 2020. The related tax effect resulted in tax expense of $13.0 and was included within income tax expense in the Consolidated Statement of Operations during the nine months ended June 30, 2020. The Company incurred $0.4 and $4.2 of transaction costs associated with the sale during the three and nine months ended June 30, 2020, respectively, which were recorded within operating expenses in the Consolidated Statement of Operations. The Company determined that the sale of Cimcool did not represent a strategic shift that had or will have a major effect on its consolidated results of operations, and therefore Cimcool was not classified as a discontinued operation. Cimcool’s results of operations were included within the Molding Technology Solutions reportable operating segment until the completion of the sale on March 30, 2020. Sale of Molding Technology Solutions facility In December 2019, the Company completed the sale of a Molding Technology Solutions manufacturing facility located in Germany. As a result of the sale, the Company received net cash proceeds of $13.1. There was no material impact to the Consolidated Statement of Operations during the nine months ended June 30, 2020, resulting from the sale of the facility.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	9 Months Ended
	Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Consolidated Balance Sheet Information June 30, September 30, Allowance for doubtful accounts $ 22.5 $ 24.0 Warranty reserves $ 25.4 $ 23.8 Accumulated depreciation on property, plant, and equipment $ 374.4 $ 342.1 Inventories, net: Raw materials and components $ 145.1 $ 133.3 Work in process $ 99.5 $ 88.7 Finished goods $ 166.3 $ 163.4 Total inventories, net $ 410.9 $ 385.4

Leases

Leases	9 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Leases	Leases The Company’s lease portfolio is comprised of operating leases primarily for manufacturing facilities, offices, vehicles, and certain equipment. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on whether the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. Leases are classified as operating or finance leases at the commencement date of the lease. Operating leases are recorded within operating lease right-of-use assets, net, other current liabilities, and operating lease liabilities in the Consolidated Balance Sheets. The Company’s finance leases were insignificant as of June 30, 2021 and September 30, 2020. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets. We have elected an accounting policy to combine lease and non-lease components for all leases. Operating lease right-of-use assets, net and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the implicit rate is generally not readily determinable for most leases, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate reflects the estimated rate of interest that the Company would pay to borrow on a collateralized basis over a similar term in a similar economic environment. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Leases may include renewal options, and the renewal option is included in the lease term if the Company concludes that it is reasonably certain that the option will be exercised. A certain number of the Company’s leases contain rent escalation clauses, either fixed or adjusted periodically for inflation of market rates, that are factored into the calculation of lease payments to the extent they are fixed and determinable at lease inception. The Company also has variable lease payments that do not depend on a rate or index, primarily for items such as common area maintenance and real estate taxes, which are recorded as variable costs when incurred. For the three and nine months ended June 30, 2021 and 2020, the Company recognized $9.0 and $26.6, and $9.2 and $27.0 respectively, of operating lease expense, including short-term lease expense and variable lease costs, which were immaterial in each period. The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases: June 30, 2021 September 30, 2020 Operating lease right-of-use assets, net $ 146.3 $ 154.4 Other current liabilities 31.9 $ 31.2 Operating lease liabilities 112.8 120.9 Total operating lease liabilities $ 144.7 $ 152.1 Weighted-average remaining lease term (in years) 7.4 7.6 Weighted-average discount rate 2.1 % 2.5 % As of June 30, 2021, the maturities of the Company’s operating lease liabilities were as follows: 2021 (excluding the nine months ended June 30, 2021) $ 9.2 2022 32.5 2023 27.0 2024 18.8 2025 12.3 Thereafter 54.8 Total lease payments 154.6 Less: imputed interest (9.9) Total present value of lease payments $ 144.7 Supplemental Consolidated Statements of Cash Flow information is as follows: Nine Months Ended June 30, 2021 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 28.9 $ 28.0 Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities 16.2 22.2

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible Assets Intangible assets are stated at the lower of cost or fair value. With the exception of most trade names, intangible assets are amortized on a straight-line basis over periods ranging from three The following tables summarize the carrying amounts and related accumulated amortization for intangible assets as of: June 30, 2021 September 30, 2020 Cost Accumulated Cost Accumulated Finite-lived assets: Trade names $ 0.2 $ (0.2) $ 0.2 $ (0.2) Customer relationships 803.4 (186.1) 787.6 (151.8) Technology, including patents 138.4 (60.4) 137.6 (51.0) Software 66.2 (58.1) 65.6 (54.1) Backlog — — 10.0 (10.0) Other — — 0.1 (0.1) 1,008.2 (304.8) 1,001.1 (267.2) Indefinite-lived assets: Trade names 227.8 — 226.8 — Total $ 1,236.0 $ (304.8) $ 1,227.9 $ (267.2) The net change in intangible assets during the three and nine months ended June 30, 2021 was driven primarily by normal amortization and foreign currency adjustments. Goodwill Goodwill is not amortized, but is subject to annual impairment tests. Goodwill has been assigned to reporting units within the reportable operating segments. The Company assesses the carrying value of goodwill annually, or more often if events or changes in circumstances indicate there may be impairment. Impairment testing is performed at a reporting unit level. The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the nine months ended June 30, 2021: Advanced Process Solutions Molding Technology Solutions Batesville Total Balance as of September 30, 2020 $ 485.1 $ 644.4 $ 8.3 $ 1,137.8 Acquisitions (1) — 19.6 — 19.6 Foreign currency adjustments 5.3 13.1 — 18.4 Balance as of June 30, 2021 $ 490.4 $ 677.1 $ 8.3 $ 1,175.8 (1) See Note 4 for further information on the acquisition of Milacron. Amount represents changes to finalizing the purchase price allocation during the nine months ended June 30, 2021.

Financing Agreements

Financing Agreements	9 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements The following table summarizes Hillenbrand’s current and long-term debt as of the dates reported in the Consolidated Balance Sheets: June 30, September 30, $500.0 term loan (1) $ — $ 473.7 $400.0 senior unsecured notes (2) 395.6 394.8 $375.0 senior unsecured notes, net of discount (3) 371.3 370.8 $350.0 senior unsecured notes (4) 345.6 — $225.0 term loan (5) — 213.4 $100.0 Series A Notes (6) 99.8 99.7 $900.0 revolving credit facility (excluding outstanding letters of credit) — — Other 0.1 0.2 Total debt 1,212.4 1,552.6 Less: current portion — 36.3 Total long-term debt $ 1,212.4 $ 1,516.3 (1) Includes unamortized debt issuance costs of $1.3 at September 30, 2020. This term loan was repaid in March 2021. (2) Includes unamortized debt issuance costs of $4.4 and $5.2 at June 30, 2021 and September 30, 2020, respectively. (3) Includes unamortized debt issuance costs of $3.3 and $3.7 at June 30, 2021 and September 30, 2020, respectively. (4) Includes unamortized debt issuance costs of $4.4 at June 30, 2021. (5) Includes unamortized debt issuance costs of $0.3 at September 30, 2020. This term loan was repaid in December 2020. (6) Includes unamortized debt issuance costs of $0.2 and $0.3 at June 30, 2021 and September 30, 2020, respectively. $350.0 senior unsecured notes On March 3, 2021, the Company issued $350.0 of senior unsecured notes due March 2031 (the “2021 Notes”). The 2021 Notes were issued at par value and bear interest at a fixed rate of 3.75% per year, payable semi-annually in arrears beginning September 2021. Deferred financing costs associated with the 2021 Notes of $4.5 are being amortized to interest expense on a straight-line basis (which approximates the effective interest method) over the term of the 2021 Notes. The 2021 Notes are unsecured unsubordinated obligations of the Company and rank equally in right of payment with all other existing and future unsubordinated obligations. Subject to certain limitations, in the event of a change of control repurchase event (as defined in the 2021 Notes), the Company will be required to make an offer to purchase the 2021 Notes at a price equal to 101% of the principal amount of the 2021 Notes, plus any accrued and unpaid interest to, but excluding, the date of repurchase. The Company may redeem the 2021 Notes at any time in whole, or from time to time in part, prior to March 1, 2026, at its option at the “make-whole” redemption price, as described in the Indenture. The Company may also redeem the 2021 Notes at any time in whole, or from time to time in part, on or after March 1 of the relevant year listed, as follows: 2026 at a redemption price of 101.875%; 2027 at a redemption price of 101.250%; 2028 at a redemption price of 100.625%; and 2029 and thereafter at a redemption price of 100.000%. At any time prior to March 1, 2024, the Company may redeem up to 40% of the aggregate principal amount of the 2021 Notes with the proceeds of one or more Equity Offerings (as defined in the Indenture) at a redemption price of 103.750% of the principal amount of the 2021 Notes being redeemed. In each of the above cases, the Company will also pay any accrued and unpaid interest to, but excluding, the applicable redemption date. Financing for Milacron Acquisition Upon completing the acquisition of Milacron on November 21, 2019, Hillenbrand incurred borrowings under its two term loans in aggregate principal amounts of $500.0 and $225.0 (the “Term Loan Facilities”), which are provided for under the Company’s Third Amended and Restated Credit Agreement dated August 28, 2019 and subsequently amended on October 8, 2019, January 10, 2020, May 29, 2020, February 2, 2021, and June 14, 2021 (as amended, the “Credit Agreement”). During the nine months ended June 30, 2021, the Company repaid the $225.0 and $500.0 term loans in full with a combination of cash on hand and borrowings from its revolving credit facility. For the nine months ended June 30, 2021, the weighted average interest rate was 2.65% for the $500.0 term loan. For the nine months ended June 30, 2021, the weighted average interest rate was 2.63% for the $225.0 term loan. For the three and nine months ended June 30, 2020, the weighted average interest rates were 2.59% and 3.07%, respectively, for the $500.0 term loan and 2.46% and 2.94%, respectively, for the $225.0 term loan. In addition to the Term Loan Facilities, Hillenbrand incurred $650.0 of borrowings from its revolving credit facility under the Credit Agreement (the “Revolver”) at the closing of the Milacron acquisition. These borrowings along with the $375.0 of senior unsecured notes issued during the year ended September 30, 2019, were used to pay a portion of the cash consideration in connection with the acquisition of Milacron and fees and expenses related to the acquisition, and to repay certain indebtedness of Milacron and its subsidiaries upon closing the acquisition. With respect to the Revolver, the Company has made net repayments since the closing date of the acquisition of Milacron, resulting in no outstanding balance as of June 30, 2021 and September 30, 2020. As of June 30, 2021, the Company had $16.5 in outstanding letters of credit issued and $883.5 of maximum borrowing capacity under the Revolver. All of this borrowing capacity was immediately available based on the Company’s most restrictive covenant at June 30, 2021. The weighted-average interest rate on borrowings under the Revolver was 2.28% for the nine months ended June 30, 2021, and 2.59% and 2.78% for the three and mine month periods in the prior year, respectively. There were no borrowings under the Revolver during the three months ended June 30, 2021. The weighted average facility fee was 0.17% and 0.24% for the three and nine months ended June 30, 2021, respectively, and 0.30% and 0.24% for the same periods in the prior year, respectively. Other credit arrangements In the normal course of business, operating companies within the Advanced Process Solutions reportable operating segment provide to certain customers bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, the Company maintains adequate capacity to provide the guarantees. As of June 30, 2021 and September 30, 2020, the Company had credit arrangements totaling $423.3 and $417.2, respectively, under which $260.2 and $261.4, respectively, was used for guarantees. These arrangements include the Company’s Syndicated Letter of Guarantee Facility (as amended, the “L/G Facility Agreement”) and other ancillary credit facilities. Amendments to current financing agreements The Company’s June 14, 2021 amendment to the Credit Agreement, among other things, amended certain provisions implemented in May 2020 in response to the COVID-19 pandemic, namely to: (i) decrease the maximum permitted leverage ratio to 3.50 to 1.00 but permit the Company to increase the maximum permitted leverage ratio to 4.00 to 1.00 for 3 consecutive fiscal quarters following certain acquisitions; (ii) decrease the applicable margin (the “Applicable Rate”) paid on revolving loans at certain pricing levels; (iii) remove additional pricing levels previously added to the Applicable Rate under certain circumstances; (iv) decrease the interest rate floor for the Alternate Base Rate (as defined in the Credit Agreement) to 1.00% and for the CDOR Screen Rate and the LIBO Screen Rate (each as defined in the Credit Agreement) to 0.00%; (v) remove the condition to each borrowing under the Revolver that, subject to certain exceptions, the amount of cash or cash equivalents on the Consolidated Balance Sheet not exceed $350.0; and (vi) remove certain restrictions on the Company’s ability to make restricted payments and grant liens on the Company’s assets that would have otherwise been in effect through January 1, 2022. The amendment also amends the Credit Agreement to include customary benchmark replacement language relating to future unavailability of certain interest rates, including the LIBO Rate (as defined in the Credit Agreement). The amendment also provides that borrowings under the Credit Agreement may bear interest (A) if denominated in US Dollars, at the LIBO Rate or the Alternate Base Rate (as defined in the Credit Agreement) at the Company’s option, (B) if denominated in Japanese Yen, Canadian Dollars or Euros, at rates based on the rates offered for deposits in the applicable interbank markets for such currencies and (C) if denominated in Pounds Sterling or Swiss Francs, at SONIA and SARON, respectively (each as defined in the Credit Agreement), plus, in each case, the Applicable Rate; and includes provisions governing erroneous payments made by the Agent to lenders part to the Credit Agreement. Covenants related to current financing agreements The Credit Agreement and the Private Shelf Agreement dated as of December 16, 2012 (as amended, the “Shelf Agreement”) among the Company, Prudential Investment Management, Inc. and each Prudential Affiliate (as defined therein) that became a purchaser thereunder, contain the following financial covenants for the current quarter: a maximum leverage ratio (as defined in the agreements) of 3.50 to 1.00 and a minimum ratio of EBITDA (as defined in the agreements) to interest expense of 3.00 to 1.00. The L/G Facility Agreement contains a maximum leverage ratio of 4.25 to 1.00 for the current quarter and a minimum ratio of EBITDA to interest expense of 3.00 to 1.00 (both as defined in such agreement). Additionally, the Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement provide the Company with the ability to sell assets and to incur debt at its international subsidiaries under certain conditions. All obligations of the Company arising under the Credit Agreement, the $400.0 of senior unsecured notes due June 2025 (the “2020 Notes”), the $375.0 of senior unsecured notes due September 2026 (the “2019 Notes”), and the 2021 Notes, the $100.0 of 4.60% Series A unsecured notes (“Series A Notes”), and the L/G Facility Agreement are fully and unconditionally, and jointly and severally, guaranteed by certain of the Company’s domestic subsidiaries. The Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement each contain certain other customary covenants, representations and warranties and events of default. The indentures governing the 2019 Notes, 2020 Notes, and 2021 Notes do not limit the Company’s ability to incur additional indebtedness. They do, however, contain certain covenants that restrict the Company’s ability to incur secured debt and to engage in certain sale and leaseback transactions. The indentures also contain customary events of default. The indentures provide holders of the senior unsecured notes with remedies if the Company fails to perform specific obligations. As of June 30, 2021, Hillenbrand was in compliance with all covenants and there were no events of default.

Retirement Benefits

Retirement Benefits	9 Months Ended
	Jun. 30, 2021
Retirement Benefits [Abstract]
Retirement Benefits	Retirement Benefits Defined Benefit Plans Components of net periodic pension (benefit) cost included in the Consolidated Statements of Operations were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits Three Months Ended June 30, Three Months Ended June 30, 2021 2020 2021 2020 Service costs $ 0.2 $ 0.4 $ 0.5 $ 0.7 Interest costs 1.5 2.0 0.2 0.2 Expected return on plan assets (2.8) (3.3) (0.2) (0.3) Amortization of net loss 0.5 1.2 0.7 0.5 Net periodic pension (benefit) cost $ (0.6) $ 0.3 $ 1.2 $ 1.1 U.S. Pension Benefits Non-U.S. Pension Benefits Nine Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Service costs $ 0.5 $ 1.1 $ 1.5 $ 1.8 Interest costs 4.4 6.0 0.5 0.5 Expected return on plan assets (8.2) (9.7) (0.6) (0.6) Amortization of net loss 1.6 3.6 2.2 1.8 Net periodic pension (benefit) cost $ (1.7) $ 1.0 $ 3.6 $ 3.5 Defined Contribution Plans

Income Taxes

Income Taxes	9 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective tax rates for the three months ended June 30, 2021 and 2020 were 37.0% and 53.1%, respectively. The difference in the effective tax rate in the three months ended June 30, 2021, relative to the federal statutory tax rate of 21%, was primarily attributable to the recognition of taxes on accumulated earnings of foreign subsidiaries and the unfavorable impact of recently enacted German tax legislation. Additionally, the decrease in the effective tax rate in the three months ended June 30, 2021, compared to the three months ended June 30, 2020, was driven by the tax effect of the utilization of tax loss carryforwards on foreign tax credit determinations related to foreign income inclusions, and nondeductible transaction costs that were recognized in the prior period that did not recur, partially offset by an unfavorable mix of geographic income and the unfavorable impact of recently enacted German tax legislation. The effective tax rates for the nine months ended June 30, 2021 and 2020 were 30.3% and (58.4)%, respectively. The difference in the effective tax rate in the nine months ended June 30, 2021 relative to the federal statutory tax rate of 21%, was primarily attributable to an unfavorable geographic mix of pretax income, the recognition of deferred taxes on accumulated earnings of foreign subsidiaries, the unfavorable impact of recently enacted German tax legislation, and the discrete recognition of the tax effect of functional currency fluctuations. Additionally, the increase in the effective tax rate in the nine months ended June 30, 2021, compared to the nine months ended June 30, 2020, was driven by the impact of the tax loss from the divestiture of Red Valve, partially offset by the tax gain on the divestiture of ABEL and the impact that utilization of tax loss carryforwards had on foreign tax credit determinations related to foreign income inclusions. The negative effective tax rate in the nine months ended June 30, 2020 was due to the net loss position and the discrete recognition of tax expense on the divestiture of Cimcool, which was partially offset by the tax benefit recognized from the revaluation of current and deferred tax balances in connection with the enacted statutory tax rate reductions in certain foreign jurisdictions.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Earnings Per Share	The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective balance sheet date. Potential dilutive effects, representing approximately 400,000 shares at both June 30, 2021 and 2020, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future. Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net income (loss) attributable to Hillenbrand $ 40.4 $ 24.0 $ 194.9 $ (53.1) Weighted-average shares outstanding (basic - in millions) (1) 75.5 75.1 75.4 72.8 Effect of dilutive stock options and other unvested equity awards (in millions) (2) 0.7 — 0.5 — Weighted-average shares outstanding (diluted - in millions) 76.2 75.1 75.9 72.8 Basic earnings (loss) per share $ 0.54 $ 0.32 $ 2.59 $ (0.73) Diluted earnings (loss) per share $ 0.53 $ 0.32 $ 2.57 $ (0.73) Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 0.1 2.8 0.8 2.9 (1) The increase in weighted-average shares outstanding during the nine months ended June 30, 2021 was due to 11.9 million of additional shares issued on November 21, 2019 in connection with the acquisition of Milacron. See Note 4 for further information. (2) As a result of the net loss attributable to Hillenbrand during the nine months ended June 30, 2020, the effect of stock options and other unvested equity awards would be antidilutive. In accordance with GAAP, they have been excluded from the diluted earnings per share calculation.

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	9 Months Ended
	Jun. 30, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of reclassifications of AOCI	Accumulated Other Comprehensive Loss The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss: Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2020 $ (69.6) $ (21.1) $ (12.1) $ (102.8) Other comprehensive income before reclassifications: Before tax amount — 43.4 0.4 43.8 $ (0.1) $ 43.7 Tax expense — — (0.1) (0.1) — (0.1) After tax amount — 43.4 0.3 43.7 (0.1) 43.6 Amounts reclassified from accumulated other comprehensive loss (1) 2.7 — 1.2 3.9 — 3.9 Net current period other comprehensive income 2.7 43.4 1.5 47.6 $ (0.1) $ 47.5 Balance at June 30, 2021 $ (66.9) $ 22.3 $ (10.6) $ (55.2) (1) Amounts are net of tax. Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2019 $ (62.3) $ (64.7) $ (13.6) $ (140.6) Other comprehensive loss before reclassifications: Before tax amount — (0.3) (1.6) (1.9) $ (0.7) $ (2.6) Tax benefit — — 0.3 0.3 — 0.3 After tax amount — (0.3) (1.3) (1.6) (0.7) (2.3) Amounts reclassified from accumulated other comprehensive loss (1) 3.8 — 1.8 5.6 — 5.6 Net current period other comprehensive income (loss) 3.8 (0.3) 0.5 4.0 $ (0.7) $ 3.3 Reclassification of certain income tax effects (2) (6.0) — — (6.0) Balance at June 30, 2020 $ (64.5) $ (65.0) $ (13.1) $ (142.6) (1) Amounts are net of tax. (2) Income tax effects of the Tax Act were reclassified from accumulated other comprehensive loss to retained earnings due to the adoption of ASU 2018-02. See Note 2 for more information. Reclassifications out of accumulated other comprehensive loss include: Three Months Ended June 30, 2021 Amortization of Pension and (1) (Gain) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Cost of goods sold $ — $ — $ (0.3) $ (0.3) Other income (expense), net 1.3 — 0.5 1.8 Total before tax $ 1.3 $ — $ 0.2 $ 1.5 Tax expense (0.3) Total reclassifications for the period, net of tax $ 1.2 Nine Months Ended June 30, 2021 Amortization of Pension and (1) Loss (Gain) on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Net revenue $ — $ — $ 0.2 $ 0.2 Cost of goods sold — — (0.6) (0.6) Other income (expense), net 3.8 (0.1) 1.5 5.2 Total before tax $ 3.8 $ (0.1) $ 1.1 $ 4.8 Tax expense (0.9) Total reclassifications for the period, net of tax $ 3.9 (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension cost (see Note 9). Three Months Ended June 30, 2020 Amortization of Pension and Postretirement (1) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Cost of goods sold $ — $ — $ 0.9 $ 0.9 Other income (expense), net 1.7 — 0.5 2.2 Total before tax $ 1.7 $ — $ 1.4 $ 3.1 Tax expense (0.5) Total reclassifications for the period, net of tax $ 2.6 Nine Months Ended June 30, 2020 Amortization of Pension and Postretirement (1) (Gain) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Net revenue $ — $ — $ (0.2) $ (0.2) Cost of goods sold — — 0.5 0.5 Other income (expense), net 5.2 (0.1) 1.5 6.6 Total before tax $ 5.2 $ (0.1) $ 1.8 $ 6.9 Tax expense (1.3) Total reclassifications for the period, net of tax $ 5.6

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Jun. 30, 2021
Compensation Related Costs [Abstract]
Share-Based Compensation	Share-Based Compensation Three Months Ended Nine Months Ended 2021 2020 2021 2020 Share-based compensation costs $ 4.3 $ 3.7 $ 14.7 $ 9.4 Less impact of income tax benefit 1.0 0.9 3.4 2.2 Share-based compensation costs, net of tax $ 3.3 $ 2.8 $ 11.3 $ 7.2 The Company has share-based compensation with long-term performance-based metrics that are contingent upon the Company’s relative total shareholder return and the creation of shareholder value. Relative total shareholder return is determined by comparing the Company’s total shareholder return during a three-year period to the respective total shareholder returns of companies in a designated performance peer group or stock index, as applicable. Creation of shareholder value is measured by the cumulative cash returns and final period net operating profit after tax compared to the established hurdle rate over a three-year period. For the performance-based awards contingent upon the creation of shareholder value, compensation expense is adjusted each quarter based upon actual results to date and any changes to forecasted information on each of the separate grants. During the nine months ended June 30, 2021, the Company made the following grants: Number of Time-based stock awards 384,507 Performance-based stock awards (maximum that can be earned) 366,923 The Company’s time-based stock awards and performance-based stock awards granted during the nine months ended June 30, 2021 had weighted-average grant date fair values of $38.80 and $44.38, respectively. Included in the performance-based stock awards granted during the nine months ended June 30, 2021 are 214,092 units whose payout level is based upon the Company’s relative total shareholder return over the three-year measurement period, as described above. These units will be expensed on a straight-line basis over the measurement period and are not subsequently adjusted after the grant date.

Other Income, Net

Other Income, Net	9 Months Ended
	Jun. 30, 2021
Other Nonoperating Income (Expense) [Abstract]
Other Income, Net	Other (Expense) Income, Net Three Months Ended Nine Months Ended 2021 2020 2021 2020 Interest income $ 0.9 $ 0.6 $ 2.5 $ 2.5 Foreign currency exchange (loss) gain, net $ (0.2) $ 0.3 $ 0.2 $ 2.2 Other, net $ (1.1) $ (0.3) $ (2.5) $ 0.1 Other (expense) income, net $ (0.4) $ 0.6 $ 0.2 $ 4.8

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Like most companies, Hillenbrand is involved from time to time in claims, lawsuits, and government proceedings relating to its operations, including environmental, patent infringement, business practices, commercial transactions, product and general liability, workers’ compensation, auto liability, employment, and other matters. The ultimate outcome of these matters cannot be predicted with certainty. An estimated loss from these contingencies is recognized when the Company believes it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated; however, it is difficult to measure the actual loss that might be incurred related to these matters. If a loss is not considered probable and/or cannot be reasonably estimated, the Company is required to make a disclosure if there is at least a reasonable possibility that a significant loss may have been incurred. Legal fees associated with claims and lawsuits are generally expensed as incurred. Claims covered by insurance have in most instances deductibles and self-funded retentions up to $0.5 per occurrence or per claim, depending upon the type of coverage and policy period. For auto, workers’ compensation, and general liability claims in the U.S., outside insurance companies and third-party claims administrators generally assist in establishing individual claim reserves. An independent outside actuary provides estimates of ultimate projected losses, including incurred but not reported claims, which are used to establish reserves for losses. For all other types of claims, reserves are established based upon advice from internal and external counsel and historical settlement information for claims when such amounts are considered probable of payment. The liabilities recorded represent the best estimate of costs that the Company will incur in relation to such exposures, but it is possible that actual costs will differ from those estimates.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability, developed based upon the best information available in the circumstances. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is broken down into three levels: Level 1: Inputs are quoted prices in active markets for identical assets or liabilities. Level 2: Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly. Level 3: Inputs are unobservable for the asset or liability. Carrying Value at June 30, 2021 Fair Value at June 30, 2021 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 476.2 $ 476.2 $ — $ — Investments in rabbi trust 4.7 4.7 — — Derivative instruments 2.6 — 2.6 — Liabilities: 2021 Notes 350.0 347.8 — — 2020 Notes 400.0 429.7 — — 2019 Notes 374.6 418.2 — — Series A Notes 100.0 — 105.7 — Derivative instruments 2.3 — 2.3 — Carrying Value at September 30, 2020 Fair Value at September 30, 2020 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 302.2 $ 302.2 $ — $ — Investments in rabbi trust 3.9 3.9 — — Derivative instruments 2.6 — 2.6 — Liabilities: $500.0 term loan 475.0 — 475.0 — 2020 Notes 400.0 429.0 — — 2019 Notes 374.5 409.0 — — $225.0 term loan 213.7 — 213.7 — Series A Notes 100.0 — 105.3 — Derivative instruments 1.6 — 1.6 — Valuation Techniques • Cash and cash equivalents and investments in rabbi trust are classified within Level 1 of the fair value hierarchy. Financial instruments classified as Level 1 are based on quoted market prices in active markets. The types of financial instruments the Company classifies within Level 1 include most bank deposits, money market securities, and publicly traded mutual funds. The Company does not adjust the quoted market price for such financial instruments. • The Company estimates the fair value of foreign currency derivatives using industry accepted models. The significant Level 2 inputs used in the valuation of derivatives include spot rates, forward rates, and volatility. These inputs were obtained from pricing services, broker quotes, and other sources. • The fair value of the amounts under the Term Loan Facilities approximated carrying value, as the Company believes their variable interest rate terms corresponded to current market terms. • The fair values of the Series A Notes were estimated based on internally-developed models, using current market interest rate data for similar issues, as there is no active market for the Series A Notes. • The fair values of the 2021 Notes, 2020 Notes, and 2019 Notes were based on quoted prices in active markets. Derivative instruments The Company has hedging programs in place to manage its currency exposures. The objectives of the Company’s hedging programs are to mitigate exposures in gross margin and non-functional-currency-denominated assets and liabilities. Under these programs, the Company uses derivative financial instruments to manage the economic impact of fluctuations in currency exchange rates. These include foreign currency exchange forward contracts, which generally have terms up to 24 months. The aggregate notional value of derivatives was $260.5 and $232.8 at June 30, 2021 and September 30, 2020, respectively. The derivatives are recorded at fair value primarily in other current assets and other current liabilities in the Consolidated Balance Sheets.

Segment and Geographical Inform

Segment and Geographical Information	9 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Segment and Geographical Information	Segment and Geographical Information The Company currently conducts operations through three reportable operating segments: Advanced Process Solutions, Molding Technology Solutions, and Batesville. The Company’s operating segments maintain separate financial information for which results of operations are evaluated on a regular basis by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company records the direct costs of business operations to the reportable operating segments, including stock-based compensation, asset impairments, restructuring activities, and business acquisition costs. Corporate provides management and administrative services to each reportable operating segment. These services include treasury management, human resources, legal, business development, and other public company support functions such as internal audit, investor relations, financial reporting, and tax compliance. With limited exception for certain professional services and back-office and technology costs, the Company does not allocate these types of corporate expenses to the reportable operating segments. The following tables present financial information for the Company’s reportable operating segments and significant geographical locations: Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Net revenue Advanced Process Solutions $ 313.4 $ 281.3 $ 905.5 $ 899.0 Molding Technology Solutions 243.8 186.3 735.7 518.6 Batesville 137.9 139.9 468.7 405.7 Total $ 695.1 $ 607.5 $ 2,109.9 $ 1,823.3 Adjusted EBITDA (1) Advanced Process Solutions $ 61.1 $ 57.6 $ 165.3 $ 166.6 Molding Technology Solutions 49.2 38.1 148.4 96.4 Batesville 29.8 36.4 126.7 91.4 Corporate (13.9) (11.1) (41.9) (30.9) Net revenue (2) United States $ 301.3 $ 298.5 $ 973.1 $ 880.2 Germany 35.2 33.5 101.9 114.7 China 135.8 98.6 362.6 225.9 India 39.0 17.7 127.5 85.8 All other countries 183.8 159.2 544.8 516.7 Total $ 695.1 $ 607.5 $ 2,109.9 $ 1,823.3 (1) Adjusted EBITDA is a non-GAAP measure used by management to measure segment performance and make operating decisions. See the Operating Performance Measures section of Management’s Discussion and Analysis for further information on adjusted EBITDA, which is reconciled to consolidated net income (loss) below. (2) The Company attributes net revenue to a geography based upon the location of the end customer. Prior to fiscal 2021, the Company attributed net revenue to a geography based upon the location of the business that consummates the external sale for purpose of this disclosure. As such, the net revenue figures for the three and nine months ended June 30, 2020, have been revised to conform to the current year methodology. June 30, September 30, Total assets Advanced Process Solutions $ 1,664.3 $ 1,666.5 Molding Technology Solutions 2,091.7 2,032.4 Batesville 228.9 225.3 Corporate 52.5 63.2 Total $ 4,037.4 $ 3,987.4 Tangible long-lived assets, net United States $ 165.8 $ 182.4 Germany 113.4 110.4 China 52.5 54.2 All other countries 109.0 121.6 Total $ 440.7 $ 468.6 The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income (loss): Three Months Ended Nine Months Ended 2021 2020 2021 2020 Adjusted EBITDA: Advanced Process Solutions $ 61.1 $ 57.6 $ 165.3 $ 166.6 Molding Technology Solutions 49.2 38.1 148.4 96.4 Batesville 29.8 36.4 126.7 91.4 Corporate (13.9) (11.1) (41.9) (30.9) Less: Interest income (0.9) (0.6) (2.5) (2.5) Interest expense 19.0 19.7 59.7 55.3 Income tax expense 24.4 28.3 86.1 17.7 Depreciation and amortization 28.7 33.9 86.3 98.4 Impairment charges — — — 82.5 Business acquisition, disposition, and integration costs 6.4 5.5 25.2 67.3 Restructuring and restructuring-related charges 6.5 3.6 10.2 6.7 Inventory step-up — 3.6 — 40.7 (Gain) loss on divestitures (0.1) — (65.8) 3.0 Other 0.7 2.0 1.1 2.4 Consolidated net income (loss) $ 41.5 $ 25.0 $ 198.2 $ (48.0)

Restructuring

Restructuring	9 Months Ended
	Jun. 30, 2021
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring The following schedule details the restructuring charges by reportable operating segment and the classification of those charges in the Consolidated Statements of Operations. Three Months Ended June 30, 2021 Three Months Ended June 30, 2020 Cost of goods sold Operating expenses Total Cost of goods sold Operating expenses Total Advanced Process Solutions $ 5.3 $ 1.9 $ 7.2 $ 0.2 $ 1.9 $ 2.1 Molding Technology Solutions 1.3 — 1.3 0.8 0.1 0.9 Batesville — 0.2 0.2 (0.1) 0.1 — Corporate — 0.1 0.1 — 0.4 0.4 Total $ 6.6 $ 2.2 $ 8.8 $ 0.9 $ 2.5 $ 3.4 Nine Months Ended June 30, 2021 Nine Months Ended June 30, 2020 Cost of goods sold Operating expenses Total Cost of goods sold Operating expenses Total Advanced Process Solutions $ 6.1 $ 3.6 $ 9.7 $ 0.9 $ 3.1 $ 4.0 Molding Technology Solutions 2.6 0.7 3.3 0.6 1.3 1.9 Batesville — 0.5 0.5 — 0.5 0.5 Corporate — 0.8 0.8 — 1.4 1.4 Total $ 8.7 $ 5.6 $ 14.3 $ 1.5 $ 6.3 $ 7.8 The restructuring charges during the three and nine months ended June 30, 2021 and 2020 related primarily to severance costs. The severance costs within the Molding Technology Solutions reportable operating segment and corporate were primarily related to the ongoing integration of Milacron. At June 30, 2021, $7.4 of restructuring costs were accrued and expected to be paid over the next twelve months. During the three months ended June 30, 2021, the Company's wholly-owned subsidiary Coperion GmbH entered into an agreement with its local works council setting forth a restructuring plan related to its manufacturing facilities in Stuttgart and Weingarten, Germany whereby certain operational functions will be shifted to the Company’s operations in Switzerland or to a third party provider (the “Plan”). As a result, the Company expects to incur severance and other related costs of approximately $13.0 to $14.0 and restructuring-related costs of $4.0 to $6.0 over the next 12 to 15 months. Substantially all of these costs will result in future cash expenditures that are expected to be substantially paid by the end of calendar year 2022. As the employees are required to render service in order to receive termination benefits, the associated liability related to the Plan will be recognized ratably over the future service period. During the three months ended June 30, 2021, the Company recognized $3.8 of expense, and these amounts were included within cost of goods sold and operating expenses in the Company's Consolidated Statements of Operations. The total liability related to the Plan was $3.8 as of June 30, 2021.

Subsequent Events

Subsequent Events	9 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsSubsequent to June 30, 2021, the Company repurchased approximately 1,289,000 shares of the Company’s common stock for approximately $56.6 during July 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Revenue	Net revenue includes gross revenue less sales discounts, customer rebates, sales incentives, and product returns, all of which require the Company to make estimates for the portion of these allowances that have yet to be credited or paid to customers. The Company estimates these allowances using the expected value method, which is based upon historical rates and projections of customer purchases toward contractual rebate thresholds.
Revenue Recognition, Deferred Revenue	Contract balances The balance in receivables from long-term manufacturing contracts at June 30, 2021 and September 30, 2020 was $124.2 and $138.1, respectively. The change was driven by the impact of net revenue recognized prior to billings. The balance in the liabilities from long-term manufacturing contracts and advances at June 30, 2021 and September 30, 2020 was $324.9 and $189.1, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The revenue recognized for the nine months ended June 30, 2021 and 2020 related to liabilities from long-term manufacturing contracts and advances as of September 30, 2020 and 2019 was $128.8 and $104.7, respectively. During the three and nine months ended June 30, 2021 and 2020, the adjustments related to performance obligations satisfied in previous periods were immaterial.

Revenue Recognition Revenue Rec

Revenue Recognition Revenue Recognition (Tables)	9 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Disaggregation of revenue The following tables present net revenue by end market: Three Months Ended June 30, 2021 Nine Months Ended June 30, 2021 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total End Market Plastics $ 225.8 $ — $ — $ 225.8 $ 630.9 $ — $ — $ 630.9 Automotive — 44.9 — 44.9 — 123.9 — 123.9 Chemicals 21.8 — — 21.8 61.1 — — 61.1 Consumer goods — 22.4 — 22.4 — 69.0 — 69.0 Food and pharmaceuticals 21.5 — — 21.5 65.1 — — 65.1 Custom molders — 28.8 — 28.8 — 110.2 — 110.2 Packaging — 29.6 — 29.6 — 95.7 — 95.7 Construction — 32.2 — 32.2 — 84.4 — 84.4 Minerals and mining 13.7 — — 13.7 38.0 — — 38.0 Electronics — 21.6 — 21.6 — 55.3 — 55.3 Medical — 23.1 — 23.1 — 65.3 — 65.3 Death care — — 137.9 137.9 — — 468.7 468.7 Other industrial 30.6 41.2 — 71.8 110.4 131.9 — 242.3 Total $ 313.4 $ 243.8 $ 137.9 $ 695.1 $ 905.5 $ 735.7 $ 468.7 $ 2,109.9 Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total End Market Plastics $ 181.0 $ — $ — $ 181.0 $ 589.6 $ — $ — $ 589.6 Automotive — 28.7 — 28.7 — 91.8 — 91.8 Chemicals 21.5 — — 21.5 69.9 — — 69.9 Consumer goods — 25.4 — 25.4 — 76.6 — 76.6 Food and pharmaceuticals 19.7 — — 19.7 54.9 — — 54.9 Custom molders — 28.4 — 28.4 — 66.5 — 66.5 Packaging — 23.8 — 23.8 — 60.5 — 60.5 Construction — 20.0 — 20.0 — 51.8 — 51.8 Minerals and mining 15.0 — — 15.0 43.7 — — 43.7 Electronics — 20.3 — 20.3 — 43.1 — 43.1 Medical — 20.4 — 20.4 — 39.7 — 39.7 Death care — — 139.9 139.9 — — 405.7 405.7 Other industrial 44.1 19.3 — 63.4 140.9 88.6 — 229.5 Total $ 281.3 $ 186.3 $ 139.9 $ 607.5 $ 899.0 $ 518.6 $ 405.7 $ 1,823.3 The following tables present net revenue by geographical market: Three Months Ended June 30, 2021 Nine Months Ended June 30, 2021 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Geographical Markets Americas $ 76.5 $ 127.9 $ 137.9 $ 342.3 $ 240.2 $ 391.4 $ 468.7 $ 1,100.3 Asia 149.1 74.0 — 223.1 411.9 218.1 — 630.0 Europe, the Middle East, and Africa 87.8 41.9 — 129.7 253.4 126.2 — 379.6 Total $ 313.4 $ 243.8 $ 137.9 $ 695.1 $ 905.5 $ 735.7 $ 468.7 $ 2,109.9 Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Geographical Markets Americas $ 93.1 $ 105.0 $ 139.9 $ 338.0 $ 306.6 $ 290.4 $ 405.7 $ 1,002.7 Asia 121.9 50.9 — 172.8 349.5 133.6 — 483.1 Europe, the Middle East, and Africa 66.3 30.4 — 96.7 242.9 94.6 — 337.5 Total $ 281.3 $ 186.3 $ 139.9 $ 607.5 $ 899.0 $ 518.6 $ 405.7 $ 1,823.3 The following tables present net revenue by products and services: Three Months Ended June 30, 2021 Nine Months Ended June 30, 2021 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Products and Services Equipment $ 219.6 $ 163.2 $ — $ 382.8 $ 621.1 $ 487.6 $ — $ 1,108.7 Parts and services 93.8 64.1 — 157.9 284.4 197.6 — 482.0 Death care — — 137.9 137.9 — — 468.7 468.7 Other — 16.5 — 16.5 — 50.5 — 50.5 Total $ 313.4 $ 243.8 $ 137.9 $ 695.1 $ 905.5 $ 735.7 $ 468.7 $ 2,109.9 Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Products and Services Equipment $ 186.7 $ 124.7 $ — $ 311.4 $ 600.6 $ 305.8 $ — $ 906.4 Parts and services 94.6 49.2 — 143.8 298.4 139.7 — 438.1 Death care — — 139.9 139.9 — — 405.7 405.7 Other — 12.4 — 12.4 — 73.1 — 73.1 Total $ 281.3 $ 186.3 $ 139.9 $ 607.5 $ 899.0 $ 518.6 $ 405.7 $ 1,823.3 The following tables present net revenue by timing of transfer: Three Months Ended June 30, 2021 Nine Months Ended June 30, 2021 Advanced Process Solutions Molding Technology Solutions Batesville Total Advanced Process Solutions Molding Technology Solutions Batesville Total Timing of Transfer Point in time $ 153.9 $ 242.6 $ 137.9 $ 534.4 $ 450.3 $ 734.5 $ 468.7 $ 1,653.5 Over time 159.5 1.2 — 160.7 455.2 1.2 — 456.4 Total $ 313.4 $ 243.8 $ 137.9 $ 695.1 $ 905.5 $ 735.7 $ 468.7 $ 2,109.9

Business Acquisitions and Div_2

Business Acquisitions and Divestitures (Tables)	9 Months Ended
	Jun. 30, 2021
Business Combinations [Abstract]
Schedule of Business Acquisition	The following table summarizes the aggregate purchase price consideration to acquire Milacron: Cash consideration paid to Milacron stockholders $ 835.9 Repayment of Milacron debt, including accrued interest 772.9 Cash consideration paid to settle outstanding share-based equity awards 34.2 Total cash consideration 1,643.0 Fair value of Hillenbrand common stock issued to Milacron stockholders (1) 356.9 Stock consideration issued to settle outstanding share-based equity awards (1) 14.4 Total consideration transferred 2,014.3 Portion of cash settlement of outstanding share-based equity awards recognized as expense (2) (14.1) Portion of stock settlement of outstanding share-based equity awards recognized as expense (2) (5.9) Total purchase price consideration $ 1,994.3 (1) The fair value of the 11.4 million shares of Hillenbrand’s common stock issued as of the acquisition date was determined based on a per share price of $31.26, which was the closing price of Hillenbrand’s common stock on November 20, 2019, the last trading day before the acquisition closed on November 21, 2019. This includes a nominal amount of cash paid in lieu of fractional shares. Additionally, 0.5 million shares of Hillenbrand’s common stock were issued to settle certain of Milacron’s outstanding share-based equity awards, as previously discussed. (2) In total, $20.0 was immediately recognized as expense within operating expenses on the Consolidated Statements of Operations during the nine months ended June 30, 2020, which represents the portion of the fair value of outstanding share-based equity awards that was not associated with pre-acquisition service of Milacron employees, as previously discussed. Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Net revenue $ 243.8 $ 186.3 $ 735.7 $ 518.6 Income (loss) before income taxes 30.9 12.0 93.3 (17.5)
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the final (as of November 21, 2020) fair values of the assets acquired and liabilities assumed as of the acquisition date (November 21, 2019). Assets acquired: Cash and cash equivalents $ 125.8 Trade receivables 133.1 Inventories 287.7 Prepaid expense and other current assets 69.2 Property, plant, and equipment 233.9 Operating lease right-of-use assets 41.3 Identifiable intangible assets 815.0 Goodwill 734.2 Other long-term assets 21.0 Total assets acquired 2,461.2 Liabilities assumed: Trade accounts payable 110.2 Liabilities from long-term manufacturing contracts and advances 32.7 Accrued compensation 20.8 Other current liabilities 89.4 Accrued pension and postretirement healthcare 29.4 Deferred income taxes 139.0 Operating lease liabilities - long-term 31.2 Other long-term liabilities 14.2 Total liabilities assumed 466.9 Total purchase price consideration $ 1,994.3 Gross Carrying Amount Weighted-Average Useful Life Customer relationships $ 560.0 19 years Trade names 150.0 Indefinite Technology, including patents 95.0 10 years Backlog 10.0 3 months Total $ 815.0
Schedule of Business Acquisition Pro Forma Information	The supplemental pro forma financial information for the periods presented is as follows: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net revenue $ 695.1 $ 607.5 $ 2,109.9 $ 1,939.0 Net income (loss) attributable to Hillenbrand 40.4 30.4 194.9 (0.7) Net income (loss) attributable to Hillenbrand — per share of common stock: Basic earnings (loss) per share $ 0.54 $ 0.40 $ 2.59 $ (0.01) Diluted earnings (loss) per share $ 0.53 $ 0.40 $ 2.57 $ (0.01)
Disposal Groups, Including Discontinued Operations	The following is a summary of the major categories of assets and liabilities that have been classified as held for sale on the Consolidated Balance Sheets: June 30, September 30, Trade receivables, net $ 6.3 $ 19.8 Inventories 12.5 22.0 Property, plant and equipment, net (1) 12.1 18.1 Operating lease right-of-use assets, net 2.0 4.3 Intangible assets, net 49.5 133.6 Goodwill 12.4 19.5 Other assets 2.5 9.4 Valuation allowance on disposal group (2) (35.9) (45.4) Total assets held for sale $ 61.4 $ 181.3 Trade accounts payable $ 4.0 $ 7.3 Liabilities from long-term manufacturing contracts and advances 5.9 4.9 Operating lease liabilities 2.2 4.5 Deferred income taxes 5.0 8.8 Other liabilities 2.1 7.0 Total liabilities held for sale $ 19.2 $ 32.5 (1) Total assets held for sale in this table include certain parcels of real estate that are also classified as held for sale on the Company’s Consolidated Balance Sheets as of June 30, 2021 and September 30, 2020. (2) The Company adjusted the carrying value to fair value less costs to sell for certain assets held for sale during the year ended September 30, 2020. There was no adjustment recognized for the three and nine months ended June 30, 2021.

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	9 Months Ended
	Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]
Schedule of supplemental balance sheet information	June 30, September 30, Allowance for doubtful accounts $ 22.5 $ 24.0 Warranty reserves $ 25.4 $ 23.8 Accumulated depreciation on property, plant, and equipment $ 374.4 $ 342.1 Inventories, net: Raw materials and components $ 145.1 $ 133.3 Work in process $ 99.5 $ 88.7 Finished goods $ 166.3 $ 163.4 Total inventories, net $ 410.9 $ 385.4

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Schedule of Supplemental Balance Sheet Information	The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases: June 30, 2021 September 30, 2020 Operating lease right-of-use assets, net $ 146.3 $ 154.4 Other current liabilities 31.9 $ 31.2 Operating lease liabilities 112.8 120.9 Total operating lease liabilities $ 144.7 $ 152.1 Weighted-average remaining lease term (in years) 7.4 7.6 Weighted-average discount rate 2.1 % 2.5 %
Schedule of Operating Lease Liability Maturities	As of June 30, 2021, the maturities of the Company’s operating lease liabilities were as follows: 2021 (excluding the nine months ended June 30, 2021) $ 9.2 2022 32.5 2023 27.0 2024 18.8 2025 12.3 Thereafter 54.8 Total lease payments 154.6 Less: imputed interest (9.9) Total present value of lease payments $ 144.7
Schedule of Supplemental Statement of Cash Flow Information	Supplemental Consolidated Statements of Cash Flow information is as follows: Nine Months Ended June 30, 2021 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 28.9 $ 28.0 Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities 16.2 22.2

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following tables summarize the carrying amounts and related accumulated amortization for intangible assets as of: June 30, 2021 September 30, 2020 Cost Accumulated Cost Accumulated Finite-lived assets: Trade names $ 0.2 $ (0.2) $ 0.2 $ (0.2) Customer relationships 803.4 (186.1) 787.6 (151.8) Technology, including patents 138.4 (60.4) 137.6 (51.0) Software 66.2 (58.1) 65.6 (54.1) Backlog — — 10.0 (10.0) Other — — 0.1 (0.1) 1,008.2 (304.8) 1,001.1 (267.2) Indefinite-lived assets: Trade names 227.8 — 226.8 — Total $ 1,236.0 $ (304.8) $ 1,227.9 $ (267.2)
Schedule of Goodwill	The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the nine months ended June 30, 2021: Advanced Process Solutions Molding Technology Solutions Batesville Total Balance as of September 30, 2020 $ 485.1 $ 644.4 $ 8.3 $ 1,137.8 Acquisitions (1) — 19.6 — 19.6 Foreign currency adjustments 5.3 13.1 — 18.4 Balance as of June 30, 2021 $ 490.4 $ 677.1 $ 8.3 $ 1,175.8
Schedule of Intangible Assets and Goodwill	The impairment charges to goodwill and the identifiable intangible assets were nondeductible for tax purposes. The following table summarizes the impairment charges recorded by the Company during the nine months ended June 30, 2020: Impairment Charges Advanced Process Solutions Molding Technology Solutions Total Goodwill $ 72.3 $ — $ 72.3 Trade names 0.7 7.9 8.6 Technology, including patents — 1.6 1.6 Total $ 73.0 $ 9.5 $ 82.5

Financing Agreements (Tables)

Financing Agreements (Tables)	9 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Schedule of borrowings under financing agreements	The following table summarizes Hillenbrand’s current and long-term debt as of the dates reported in the Consolidated Balance Sheets: June 30, September 30, $500.0 term loan (1) $ — $ 473.7 $400.0 senior unsecured notes (2) 395.6 394.8 $375.0 senior unsecured notes, net of discount (3) 371.3 370.8 $350.0 senior unsecured notes (4) 345.6 — $225.0 term loan (5) — 213.4 $100.0 Series A Notes (6) 99.8 99.7 $900.0 revolving credit facility (excluding outstanding letters of credit) — — Other 0.1 0.2 Total debt 1,212.4 1,552.6 Less: current portion — 36.3 Total long-term debt $ 1,212.4 $ 1,516.3 (1) Includes unamortized debt issuance costs of $1.3 at September 30, 2020. This term loan was repaid in March 2021. (2) Includes unamortized debt issuance costs of $4.4 and $5.2 at June 30, 2021 and September 30, 2020, respectively. (3) Includes unamortized debt issuance costs of $3.3 and $3.7 at June 30, 2021 and September 30, 2020, respectively. (4) Includes unamortized debt issuance costs of $4.4 at June 30, 2021. (5) Includes unamortized debt issuance costs of $0.3 at September 30, 2020. This term loan was repaid in December 2020.

Retirement Benefits (Tables)

Retirement Benefits (Tables)	9 Months Ended
	Jun. 30, 2021
Retirement Benefits [Abstract]
Components of net pension costs	o

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted earnings per share	Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net income (loss) attributable to Hillenbrand $ 40.4 $ 24.0 $ 194.9 $ (53.1) Weighted-average shares outstanding (basic - in millions) (1) 75.5 75.1 75.4 72.8 Effect of dilutive stock options and other unvested equity awards (in millions) (2) 0.7 — 0.5 — Weighted-average shares outstanding (diluted - in millions) 76.2 75.1 75.9 72.8 Basic earnings (loss) per share $ 0.54 $ 0.32 $ 2.59 $ (0.73) Diluted earnings (loss) per share $ 0.53 $ 0.32 $ 2.57 $ (0.73) Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 0.1 2.8 0.8 2.9 (1) The increase in weighted-average shares outstanding during the nine months ended June 30, 2021 was due to 11.9 million of additional shares issued on November 21, 2019 in connection with the acquisition of Milacron. See Note 4 for further information. (2) As a result of the net loss attributable to Hillenbrand during the nine months ended June 30, 2020, the effect of stock options and other unvested equity awards would be antidilutive. In accordance with GAAP, they have been excluded from the diluted earnings per share calculation.

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Jun. 30, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of changes in accumulated other comprehensive income (loss) by component	Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2019 $ (62.3) $ (64.7) $ (13.6) $ (140.6) Other comprehensive loss before reclassifications: Before tax amount — (0.3) (1.6) (1.9) $ (0.7) $ (2.6) Tax benefit — — 0.3 0.3 — 0.3 After tax amount — (0.3) (1.3) (1.6) (0.7) (2.3) Amounts reclassified from accumulated other comprehensive loss (1) 3.8 — 1.8 5.6 — 5.6 Net current period other comprehensive income (loss) 3.8 (0.3) 0.5 4.0 $ (0.7) $ 3.3 Reclassification of certain income tax effects (2) (6.0) — — (6.0) Balance at June 30, 2020 $ (64.5) $ (65.0) $ (13.1) $ (142.6)
Schedule of reclassifications of AOCI	Accumulated Other Comprehensive Loss The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss: Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2020 $ (69.6) $ (21.1) $ (12.1) $ (102.8) Other comprehensive income before reclassifications: Before tax amount — 43.4 0.4 43.8 $ (0.1) $ 43.7 Tax expense — — (0.1) (0.1) — (0.1) After tax amount — 43.4 0.3 43.7 (0.1) 43.6 Amounts reclassified from accumulated other comprehensive loss (1) 2.7 — 1.2 3.9 — 3.9 Net current period other comprehensive income 2.7 43.4 1.5 47.6 $ (0.1) $ 47.5 Balance at June 30, 2021 $ (66.9) $ 22.3 $ (10.6) $ (55.2) (1) Amounts are net of tax. Pension and Currency Net Total Noncontrolling Total Balance at September 30, 2019 $ (62.3) $ (64.7) $ (13.6) $ (140.6) Other comprehensive loss before reclassifications: Before tax amount — (0.3) (1.6) (1.9) $ (0.7) $ (2.6) Tax benefit — — 0.3 0.3 — 0.3 After tax amount — (0.3) (1.3) (1.6) (0.7) (2.3) Amounts reclassified from accumulated other comprehensive loss (1) 3.8 — 1.8 5.6 — 5.6 Net current period other comprehensive income (loss) 3.8 (0.3) 0.5 4.0 $ (0.7) $ 3.3 Reclassification of certain income tax effects (2) (6.0) — — (6.0) Balance at June 30, 2020 $ (64.5) $ (65.0) $ (13.1) $ (142.6) (1) Amounts are net of tax. (2) Income tax effects of the Tax Act were reclassified from accumulated other comprehensive loss to retained earnings due to the adoption of ASU 2018-02. See Note 2 for more information. Reclassifications out of accumulated other comprehensive loss include: Three Months Ended June 30, 2021 Amortization of Pension and (1) (Gain) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Cost of goods sold $ — $ — $ (0.3) $ (0.3) Other income (expense), net 1.3 — 0.5 1.8 Total before tax $ 1.3 $ — $ 0.2 $ 1.5 Tax expense (0.3) Total reclassifications for the period, net of tax $ 1.2 Nine Months Ended June 30, 2021 Amortization of Pension and (1) Loss (Gain) on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Net revenue $ — $ — $ 0.2 $ 0.2 Cost of goods sold — — (0.6) (0.6) Other income (expense), net 3.8 (0.1) 1.5 5.2 Total before tax $ 3.8 $ (0.1) $ 1.1 $ 4.8 Tax expense (0.9) Total reclassifications for the period, net of tax $ 3.9 (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension cost (see Note 9). Three Months Ended June 30, 2020 Amortization of Pension and Postretirement (1) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Cost of goods sold $ — $ — $ 0.9 $ 0.9 Other income (expense), net 1.7 — 0.5 2.2 Total before tax $ 1.7 $ — $ 1.4 $ 3.1 Tax expense (0.5) Total reclassifications for the period, net of tax $ 2.6 Nine Months Ended June 30, 2020 Amortization of Pension and Postretirement (1) (Gain) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Net revenue $ — $ — $ (0.2) $ (0.2) Cost of goods sold — — 0.5 0.5 Other income (expense), net 5.2 (0.1) 1.5 6.6 Total before tax $ 5.2 $ (0.1) $ 1.8 $ 6.9 Tax expense (1.3) Total reclassifications for the period, net of tax $ 5.6

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Jun. 30, 2021
Compensation Related Costs [Abstract]
Schedule of stock-based compensation costs	Three Months Ended Nine Months Ended 2021 2020 2021 2020 Share-based compensation costs $ 4.3 $ 3.7 $ 14.7 $ 9.4 Less impact of income tax benefit 1.0 0.9 3.4 2.2 Share-based compensation costs, net of tax $ 3.3 $ 2.8 $ 11.3 $ 7.2
Schedule of stock-based awards granted in the period	During the nine months ended June 30, 2021, the Company made the following grants: Number of Time-based stock awards 384,507 Performance-based stock awards (maximum that can be earned) 366,923

Other Income, Net (Tables)

Other Income, Net (Tables)	9 Months Ended
	Jun. 30, 2021
Other Nonoperating Income (Expense) [Abstract]
Other income and expense	Three Months Ended Nine Months Ended 2021 2020 2021 2020 Interest income $ 0.9 $ 0.6 $ 2.5 $ 2.5 Foreign currency exchange (loss) gain, net $ (0.2) $ 0.3 $ 0.2 $ 2.2 Other, net $ (1.1) $ (0.3) $ (2.5) $ 0.1 Other (expense) income, net $ (0.4) $ 0.6 $ 0.2 $ 4.8

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of financial assets and liabilities at carrying value and fair value and the level within the fair value hierarchy	Carrying Value at June 30, 2021 Fair Value at June 30, 2021 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 476.2 $ 476.2 $ — $ — Investments in rabbi trust 4.7 4.7 — — Derivative instruments 2.6 — 2.6 — Liabilities: 2021 Notes 350.0 347.8 — — 2020 Notes 400.0 429.7 — — 2019 Notes 374.6 418.2 — — Series A Notes 100.0 — 105.7 — Derivative instruments 2.3 — 2.3 — Carrying Value at September 30, 2020 Fair Value at September 30, 2020 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 302.2 $ 302.2 $ — $ — Investments in rabbi trust 3.9 3.9 — — Derivative instruments 2.6 — 2.6 — Liabilities: $500.0 term loan 475.0 — 475.0 — 2020 Notes 400.0 429.0 — — 2019 Notes 374.5 409.0 — — $225.0 term loan 213.7 — 213.7 — Series A Notes 100.0 — 105.3 — Derivative instruments 1.6 — 1.6 —

Segment and Geographical Info_2

Segment and Geographical Information (Tables)	9 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Schedule of net revenue, adjusted EBITDA, and depreciation and amortization by segment and geographic location	Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Net revenue Advanced Process Solutions $ 313.4 $ 281.3 $ 905.5 $ 899.0 Molding Technology Solutions 243.8 186.3 735.7 518.6 Batesville 137.9 139.9 468.7 405.7 Total $ 695.1 $ 607.5 $ 2,109.9 $ 1,823.3 Adjusted EBITDA (1) Advanced Process Solutions $ 61.1 $ 57.6 $ 165.3 $ 166.6 Molding Technology Solutions 49.2 38.1 148.4 96.4 Batesville 29.8 36.4 126.7 91.4 Corporate (13.9) (11.1) (41.9) (30.9) Net revenue (2) United States $ 301.3 $ 298.5 $ 973.1 $ 880.2 Germany 35.2 33.5 101.9 114.7 China 135.8 98.6 362.6 225.9 India 39.0 17.7 127.5 85.8 All other countries 183.8 159.2 544.8 516.7 Total $ 695.1 $ 607.5 $ 2,109.9 $ 1,823.3 (1) Adjusted EBITDA is a non-GAAP measure used by management to measure segment performance and make operating decisions. See the Operating Performance Measures section of Management’s Discussion and Analysis for further information on adjusted EBITDA, which is reconciled to consolidated net income (loss) below. (2) The Company attributes net revenue to a geography based upon the location of the end customer. Prior to fiscal 2021, the Company attributed net revenue to a geography based upon the location of the business that consummates the external sale for purpose of this disclosure. As such, the net revenue figures for the three and nine months ended June 30, 2020, have been revised to conform to the current year methodology.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas	June 30, September 30, Total assets Advanced Process Solutions $ 1,664.3 $ 1,666.5 Molding Technology Solutions 2,091.7 2,032.4 Batesville 228.9 225.3 Corporate 52.5 63.2 Total $ 4,037.4 $ 3,987.4 Tangible long-lived assets, net United States $ 165.8 $ 182.4 Germany 113.4 110.4 China 52.5 54.2 All other countries 109.0 121.6 Total $ 440.7 $ 468.6
Schedule of reconciliation of segment adjusted EBITDA to consolidated net income	The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income (loss): Three Months Ended Nine Months Ended 2021 2020 2021 2020 Adjusted EBITDA: Advanced Process Solutions $ 61.1 $ 57.6 $ 165.3 $ 166.6 Molding Technology Solutions 49.2 38.1 148.4 96.4 Batesville 29.8 36.4 126.7 91.4 Corporate (13.9) (11.1) (41.9) (30.9) Less: Interest income (0.9) (0.6) (2.5) (2.5) Interest expense 19.0 19.7 59.7 55.3 Income tax expense 24.4 28.3 86.1 17.7 Depreciation and amortization 28.7 33.9 86.3 98.4 Impairment charges — — — 82.5 Business acquisition, disposition, and integration costs 6.4 5.5 25.2 67.3 Restructuring and restructuring-related charges 6.5 3.6 10.2 6.7 Inventory step-up — 3.6 — 40.7 (Gain) loss on divestitures (0.1) — (65.8) 3.0 Other 0.7 2.0 1.1 2.4 Consolidated net income (loss) $ 41.5 $ 25.0 $ 198.2 $ (48.0)

Restructuring Schedule of restr

Restructuring Schedule of restructuring charges by line and segment (Tables)	9 Months Ended
	Jun. 30, 2021
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	The following schedule details the restructuring charges by reportable operating segment and the classification of those charges in the Consolidated Statements of Operations. Three Months Ended June 30, 2021 Three Months Ended June 30, 2020 Cost of goods sold Operating expenses Total Cost of goods sold Operating expenses Total Advanced Process Solutions $ 5.3 $ 1.9 $ 7.2 $ 0.2 $ 1.9 $ 2.1 Molding Technology Solutions 1.3 — 1.3 0.8 0.1 0.9 Batesville — 0.2 0.2 (0.1) 0.1 — Corporate — 0.1 0.1 — 0.4 0.4 Total $ 6.6 $ 2.2 $ 8.8 $ 0.9 $ 2.5 $ 3.4 Nine Months Ended June 30, 2021 Nine Months Ended June 30, 2020 Cost of goods sold Operating expenses Total Cost of goods sold Operating expenses Total Advanced Process Solutions $ 6.1 $ 3.6 $ 9.7 $ 0.9 $ 3.1 $ 4.0 Molding Technology Solutions 2.6 0.7 3.3 0.6 1.3 1.9 Batesville — 0.5 0.5 — 0.5 0.5 Corporate — 0.8 0.8 — 1.4 1.4 Total $ 8.7 $ 5.6 $ 14.3 $ 1.5 $ 6.3 $ 7.8

Background and Basis of Prese_2

Background and Basis of Presentation - Narrative (Details)	9 Months Ended
	Jun. 30, 2021segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	3
Acquired entity subsidiary investments owned percent	100.00%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Oct. 01, 2019	Sep. 30, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity	$ 1,252.4	$ 1,235.7	$ 1,079.4	$ 1,055.1	$ 1,027		$ 769.8
Cumulative Effect, Period of Adoption, Adjustment
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity							0
Retained Earnings [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity	627.1	603.1	481.4	504.4	496.4		599.5
Retained Earnings [Member] | Cumulative Effect, Period of Adoption, Adjustment
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity							6
Retained Earnings [Member] | Accounting Standards Update 2018-02 [Member] | Cumulative Effect, Period of Adoption, Adjustment
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity						$ 6
AOCI Attributable to Parent [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity	$ (55.2)	$ (85.8)	$ (102.8)	$ (142.6)	$ (158.3)		(140.6)
AOCI Attributable to Parent [Member] | Cumulative Effect, Period of Adoption, Adjustment
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity							$ (6)
AOCI Attributable to Parent [Member] | Accounting Standards Update 2018-02 [Member] | Cumulative Effect, Period of Adoption, Adjustment
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' equity						$ 6

Revenue Recognition Narrative (

Revenue Recognition Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Receivables from long-term manufacturing contracts	$ 124.2		$ 138.1
Liabilities from long-term manufacturing contracts and advances	324.9		$ 189.1
Revenue recognized on long-term manufacturing contracts and advances liabilities	$ 128.8	$ 104.7

Revenue Recognition Revenue Rem

Revenue Recognition Revenue Remaining Performance Obligation Narrative (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-04-01 $ in Millions	Jun. 30, 2021USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	6 months
Revenue, Remaining Performance Obligation, Amount	$ 1,765.9
Remaining performance obligation expected to be recognized in the given period (as a percent)	76.00%

Revenue Recognition Revenue by

Revenue Recognition Revenue by End Market (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 695.1	$ 607.5	$ 2,109.9	$ 1,823.3
Plastics
Disaggregation of Revenue [Line Items]
Net revenue	225.8	181	630.9	589.6
Automotive
Disaggregation of Revenue [Line Items]
Net revenue	44.9	28.7	123.9	91.8
Chemicals
Disaggregation of Revenue [Line Items]
Net revenue	21.8	21.5	61.1	69.9
Consumer goods
Disaggregation of Revenue [Line Items]
Net revenue	22.4	25.4	69	76.6
Food and pharmaceuticals
Disaggregation of Revenue [Line Items]
Net revenue	21.5	19.7	65.1	54.9
Custom molders
Disaggregation of Revenue [Line Items]
Net revenue	28.8	28.4	110.2	66.5
Construction
Disaggregation of Revenue [Line Items]
Net revenue	29.6	23.8	95.7	60.5
Packaging
Disaggregation of Revenue [Line Items]
Net revenue	32.2	20	84.4	51.8
Minerals and mining
Disaggregation of Revenue [Line Items]
Net revenue	13.7	15	38	43.7
Electronics
Disaggregation of Revenue [Line Items]
Net revenue	21.6	20.3	55.3	43.1
Medical
Disaggregation of Revenue [Line Items]
Net revenue	23.1	20.4	65.3	39.7
Death care
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Other industrial
Disaggregation of Revenue [Line Items]
Net revenue	71.8	63.4	242.3	229.5
Advanced Process Solutions
Disaggregation of Revenue [Line Items]
Net revenue	313.4	281.3	905.5	899
Advanced Process Solutions | Plastics
Disaggregation of Revenue [Line Items]
Net revenue	225.8	181	630.9	589.6
Advanced Process Solutions | Automotive
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Chemicals
Disaggregation of Revenue [Line Items]
Net revenue	21.8	21.5	61.1	69.9
Advanced Process Solutions | Consumer goods
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Food and pharmaceuticals
Disaggregation of Revenue [Line Items]
Net revenue	21.5	19.7	65.1	54.9
Advanced Process Solutions | Custom molders
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Construction
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Packaging
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Minerals and mining
Disaggregation of Revenue [Line Items]
Net revenue	13.7	15	38	43.7
Advanced Process Solutions | Electronics
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Medical
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Death care
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Other industrial
Disaggregation of Revenue [Line Items]
Net revenue	30.6	44.1	110.4	140.9
Molding Technology Solutions
Disaggregation of Revenue [Line Items]
Net revenue	243.8	186.3	735.7	518.6
Molding Technology Solutions | Plastics
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Molding Technology Solutions | Automotive
Disaggregation of Revenue [Line Items]
Net revenue	44.9	28.7	123.9	91.8
Molding Technology Solutions | Chemicals
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Molding Technology Solutions | Consumer goods
Disaggregation of Revenue [Line Items]
Net revenue	22.4	25.4	69	76.6
Molding Technology Solutions | Food and pharmaceuticals
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Molding Technology Solutions | Custom molders
Disaggregation of Revenue [Line Items]
Net revenue	28.8	28.4	110.2	66.5
Molding Technology Solutions | Construction
Disaggregation of Revenue [Line Items]
Net revenue	29.6	23.8	95.7	60.5
Molding Technology Solutions | Packaging
Disaggregation of Revenue [Line Items]
Net revenue	32.2	20	84.4	51.8
Molding Technology Solutions | Minerals and mining
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Molding Technology Solutions | Electronics
Disaggregation of Revenue [Line Items]
Net revenue	21.6	20.3	55.3	43.1
Molding Technology Solutions | Medical
Disaggregation of Revenue [Line Items]
Net revenue	23.1	20.4	65.3	39.7
Molding Technology Solutions | Death care
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Molding Technology Solutions | Other industrial
Disaggregation of Revenue [Line Items]
Net revenue	41.2	19.3	131.9	88.6
Batesville
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Batesville | Plastics
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Automotive
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Chemicals
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Consumer goods
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Food and pharmaceuticals
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Custom molders
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Construction
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Packaging
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Minerals and mining
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Electronics
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Medical
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Death care
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Batesville | Other industrial
Disaggregation of Revenue [Line Items]
Net revenue	$ 0	$ 0	$ 0	$ 0

Revenue Recognition by Geograph

Revenue Recognition by Geographic Markets (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 695.1	$ 607.5	$ 2,109.9	$ 1,823.3
Americas
Disaggregation of Revenue [Line Items]
Net revenue	342.3	338	1,100.3	1,002.7
Asia
Disaggregation of Revenue [Line Items]
Net revenue	223.1	172.8	630	483.1
Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	129.7	96.7	379.6	337.5
Advanced Process Solutions
Disaggregation of Revenue [Line Items]
Net revenue	313.4	281.3	905.5	899
Advanced Process Solutions | Americas
Disaggregation of Revenue [Line Items]
Net revenue	76.5	93.1	240.2	306.6
Advanced Process Solutions | Asia
Disaggregation of Revenue [Line Items]
Net revenue	149.1	121.9	411.9	349.5
Advanced Process Solutions | Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	87.8	66.3	253.4	242.9
Molding Technology Solutions
Disaggregation of Revenue [Line Items]
Net revenue	243.8	186.3	735.7	518.6
Molding Technology Solutions | Americas
Disaggregation of Revenue [Line Items]
Net revenue	127.9	105	391.4	290.4
Molding Technology Solutions | Asia
Disaggregation of Revenue [Line Items]
Net revenue	74	50.9	218.1	133.6
Molding Technology Solutions | Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	41.9	30.4	126.2	94.6
Batesville
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Batesville | Americas
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Batesville | Asia
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	$ 0	$ 0	$ 0	$ 0

Revenue Recognition Timing of T

Revenue Recognition Timing of Transfer (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 695.1	$ 607.5	$ 2,109.9	$ 1,823.3
Point in time
Disaggregation of Revenue [Line Items]
Net revenue	534.4	477.8	1,653.5	1,372.6
Over time
Disaggregation of Revenue [Line Items]
Net revenue	160.7	129.7	456.4	450.7
Advanced Process Solutions
Disaggregation of Revenue [Line Items]
Net revenue	313.4	281.3	905.5	899
Advanced Process Solutions | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	153.9	151.6	450.3	448.3
Advanced Process Solutions | Over time
Disaggregation of Revenue [Line Items]
Net revenue	159.5	129.7	455.2	450.7
Molding Technology Solutions
Disaggregation of Revenue [Line Items]
Net revenue	243.8	186.3	735.7	518.6
Molding Technology Solutions | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	242.6	186.3	734.5	518.6
Molding Technology Solutions | Over time
Disaggregation of Revenue [Line Items]
Net revenue	1.2	0	1.2	0
Batesville
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Batesville | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Batesville | Over time
Disaggregation of Revenue [Line Items]
Net revenue	$ 0	$ 0	$ 0	$ 0

Revenue Recognition Product and

Revenue Recognition Product and Services (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Net revenue	$ 695.1	$ 607.5	$ 2,109.9	$ 1,823.3
Equipment
Disaggregation of Revenue [Line Items]
Net revenue		311.4
Equipment
Disaggregation of Revenue [Line Items]
Net revenue	382.8		1,108.7	906.4
Parts and services
Disaggregation of Revenue [Line Items]
Net revenue	157.9	143.8	482	438.1
Death care
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Other
Disaggregation of Revenue [Line Items]
Net revenue	16.5	12.4	50.5	73.1
Advanced Process Solutions
Disaggregation of Revenue [Line Items]
Net revenue	313.4	281.3	905.5	899
Advanced Process Solutions | Equipment
Disaggregation of Revenue [Line Items]
Net revenue		186.7
Advanced Process Solutions | Equipment
Disaggregation of Revenue [Line Items]
Net revenue	219.6		621.1	600.6
Advanced Process Solutions | Parts and services
Disaggregation of Revenue [Line Items]
Net revenue	93.8	94.6	284.4	298.4
Advanced Process Solutions | Death care
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Advanced Process Solutions | Other
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Molding Technology Solutions
Disaggregation of Revenue [Line Items]
Net revenue	243.8	186.3	735.7	518.6
Molding Technology Solutions | Equipment
Disaggregation of Revenue [Line Items]
Net revenue		124.7		305.8
Molding Technology Solutions | Equipment
Disaggregation of Revenue [Line Items]
Net revenue	163.2		487.6
Molding Technology Solutions | Parts and services
Disaggregation of Revenue [Line Items]
Net revenue	64.1	49.2	197.6	139.7
Molding Technology Solutions | Death care
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Molding Technology Solutions | Other
Disaggregation of Revenue [Line Items]
Net revenue	16.5	12.4	50.5	73.1
Batesville
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Batesville | Equipment
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Parts and services
Disaggregation of Revenue [Line Items]
Net revenue	0	0	0	0
Batesville | Death care
Disaggregation of Revenue [Line Items]
Net revenue	137.9	139.9	468.7	405.7
Batesville | Other
Disaggregation of Revenue [Line Items]
Net revenue	$ 0	$ 0	$ 0	$ 0

Business Acquisitions and Div_3

Business Acquisitions and Divestitures - Narrative (Details) $ / shares in Units, shares in Millions	Mar. 10, 2021USD ($)	Mar. 30, 2020USD ($)	Nov. 21, 2019USD ($)$ / sharesshares	Dec. 31, 2019USD ($)	Jun. 30, 2021USD ($)	Mar. 31, 2021USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)	Dec. 31, 2020USD ($)
Business Acquisition [Line Items]
Proceeds from divestiture of businesses				$ 13,100,000
Proceeds from divestitures, net of cash divested		$ 165,800,000							$ 222,400,000
Pre-tax gain (loss)					$ 100,000		$ 0	$ 65,800,000	(3,000,000)
Molding Technology Solutions
Business Acquisition [Line Items]
Business acquisition and integration costs					5,100,000		5,000,000	17,400,000	62,700,000
Percentage of voting interests acquired			100.00%
Share price (in dollars per share) | $ / shares			$ 11.80
Exchange ratio of common stock issued (in shares)			0.1612
Payments to acquire business, gross			$ 1,643,000,000
Business acquisition, common stock shares issued (in shares) | shares			11.4
Repayment of Milacron debt, including accrued interest			$ 772,900,000
Identifiable intangible assets					815,000,000			815,000,000
Cimcool
Business Acquisition [Line Items]
Proceeds from divestitures, net of cash divested		$ 222,400,000
Cimcool | Discontinued Operations, Disposed of by Sale [Member]
Business Acquisition [Line Items]
Tax expense									13,000,000
Cimcool | Level 2 | Discontinued Operations, Disposed of by Sale [Member]
Business Acquisition [Line Items]
Pre-tax gain (loss)									(3,000,000)
Red Valve
Business Acquisition [Line Items]
Total transaction value										$ 63,000,000
Proceeds from divestiture of businesses						$ 59,400,000
Pre-tax gain (loss)								(31,600,000)
Trade receivables, net						$ 5,000,000
Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation								3,800,000
Discontinued Operation, Transaction Costs								2,900,000
ABEL
Business Acquisition [Line Items]
Proceeds from divestitures, net of cash divested	$ 103,500,000
Pre-tax gain (loss)					34,200,000			34,200,000
Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation					6,900,000			$ 6,900,000
Discontinued Operation, Transaction Costs					$ 3,900,000		$ 400,000		$ 4,200,000
Proceeds from Divestiture of Businesses, Including Working Capital Adjustments	$ 106,300,000

Business Acquisitions and Div_4

Business Acquisitions and Divestitures - Schedule of Aggregate Purchase Price Consideration (Details) - Molding Technology Solutions - USD ($) $ / shares in Units, shares in Millions, $ in Millions	Nov. 21, 2019	Jun. 30, 2021
Business Acquisition [Line Items]
Cash consideration paid to Milacron stockholders	$ 835.9
Repayment of Milacron debt, including accrued interest	772.9
Cash consideration paid to settle outstanding share-based equity awards	34.2
Total cash consideration	1,643
Fair value of Hillenbrand common stock issued to Milacron stockholders	356.9
Stock consideration issued to settle outstanding share-based equity awards	14.4
Total consideration transferred	2,014.3
Portion of cash settlement of outstanding share-based equity awards recognized as expense	(14.1)
Portion of stock settlement of outstanding share-based equity awards recognized as expense	(5.9)
Total purchase price consideration	$ 1,994.3
Business acquisition, common stock shares issued (in shares)	11.4
Business acquisition, common stock shares issued (in in dollars per share)	$ 31.26
Shares issued to settle outstanding share-based equity awards (in shares)	0.5
Settlement of outstanding share-based equity awards recognized as expense		$ 20

Business Acquisitions and Div_5

Business Acquisitions and Divestitures - Schedule of Assets and Liabilities Assumed (Details) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Assets acquired:
Goodwill	$ 1,175.8	$ 1,137.8
Molding Technology Solutions
Assets acquired:
Cash and cash equivalents	125.8
Trade receivables	133.1
Inventories	287.7
Prepaid expense and other current assets	69.2
Property, plant, and equipment	233.9
Operating lease right-of-use assets	41.3
Identifiable intangible assets	815
Goodwill	734.2
Other long-term assets	21
Total assets acquired	2,461.2
Liabilities assumed:
Trade accounts payable	110.2
Liabilities from long-term manufacturing contracts and advances	32.7
Accrued compensation	20.8
Other current liabilities	89.4
Accrued pension and postretirement healthcare	29.4
Deferred income taxes	139
Operating lease liabilities - long-term	31.2
Other long-term liabilities	14.2
Total liabilities assumed	466.9
Total purchase price consideration	$ 1,994.3

Business Acquisitions and Div_6

Business Acquisitions and Divestitures - Schedule of Intangible Assets Acquired (Details) - Molding Technology Solutions - USD ($) $ in Millions	Nov. 21, 2019	Jun. 30, 2021
Business Acquisition [Line Items]
Identifiable intangible assets		$ 815
Customer relationships
Business Acquisition [Line Items]
Gross Carrying Amount	$ 560
Weighted-Average Useful Life	19 years
Trade names
Business Acquisition [Line Items]
Gross Carrying Amount	$ 150
Technology, including patents
Business Acquisition [Line Items]
Gross Carrying Amount	$ 95
Weighted-Average Useful Life	10 years
Backlog
Business Acquisition [Line Items]
Gross Carrying Amount	$ 10
Weighted-Average Useful Life	3 months

Business Acquisitions and Div_7

Business Acquisitions and Divestitures - Schedule of Results of Operations After Acquisition (Details) - USD ($) $ in Millions	Mar. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Business Acquisition [Line Items]
Proceeds from divestitures, net of cash divested	$ 165.8				$ 222.4
Net revenue		$ 695.1	$ 607.5	$ 2,109.9	1,823.3
Income before income taxes		65.9	53.3	284.3	(30.3)
Molding Technology Solutions
Business Acquisition [Line Items]
Net revenue		243.8	186.3	735.7	518.6
Income before income taxes		$ 30.9	$ 12	$ 93.3	$ (17.5)

Business Acquisitions and Div_8

Business Acquisitions and Divestitures - Schedule of Supplemental Pro Forma Financial Information (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Business Combinations [Abstract]
Net revenue	$ 695.1	$ 607.5	$ 2,109.9	$ 1,939
Net income (loss) attributable to Hillenbrand	$ 40.4	$ 30.4	$ 194.9	$ (0.7)
Net income (loss) attributable to Hillenbrand — per share of common stock:
Basic earnings (loss) per share	$ 0.54	$ 0.40	$ 2.59	$ (0.01)
Diluted earnings (loss) per share	$ 0.53	$ 0.40	$ 2.57	$ (0.01)

Business Acquisitions and Div_9

Business Acquisitions and Divestitures - Disposal Group Balance Sheet Disclosures (Details) - TerraSource Global - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Disposal Group, Including Discontinued Operation, Assets [Abstract]
Trade receivables, net	$ 6.3	$ 19.8
Inventories	12.5	22
Property, plant and equipment, net (1)	12.1	18.1
Operating lease right-of-use assets, net	2	4.3
Intangible assets, net	49.5	133.6
Goodwill	12.4	19.5
Other assets	2.5	9.4
Valuation allowance on disposal group (2)	(35.9)	(45.4)
Total assets held for sale	61.4	181.3
Disposal Group, Including Discontinued Operation, Liabilities [Abstract]
Trade accounts payable	4	7.3
Liabilities from long-term manufacturing contracts and advances	5.9	4.9
Operating lease liabilities	2.2	4.5
Deferred income taxes	5	8.8
Other liabilities	2.1	7
Total liabilities held for sale	$ 19.2	$ 32.5

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information - Schedule of supplemental balance sheet information (Details) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020	Jun. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Restricted Cash and Cash Equivalents	$ 1.5		$ 1.8
Allowance for doubtful accounts	22.5	$ 24
Warranty reserves	25.4	23.8
Accumulated depreciation on property, plant, and equipment	374.4	342.1
Inventories, net:
Raw materials and components	145.1	133.3
Work in process	99.5	88.7
Finished goods	166.3	163.4
Total inventories, net	$ 410.9	$ 385.4

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Leases [Abstract]
Operating lease expense	$ 9,000,000	$ 9,200,000	$ 26,600,000	$ 27,000,000

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Operating lease right-of-use assets, net	$ 146.3	$ 154.4
Other current liabilities	31.9	31.2
Operating lease liabilities	112.8	120.9
Total operating lease liabilities	$ 144.7	$ 152.1
Weighted-average remaining lease term (in years)	7 years 4 months 24 days	7 years 7 months 6 days
Weighted-average discount rate	2.10%	2.50%

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Liability Maturities (Details) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Leases [Abstract]
2021 (excluding the nine months ended June 30, 2021)	$ 9.2
2022	32.5
2023	27
2024	12.3
Thereafter	54.8
Total lease payments	154.6
Less: imputed interest	(9.9)
Total present value of lease payments	144.7	$ 152.1
2022	$ 18.8

Leases - Schedule fo Supplement

Leases - Schedule fo Supplemental Statement of Cash Flow Information (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 28.9	$ 28
Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities	$ 16.2	$ 22.2

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment				$ 72.3
Impairment charges	$ 0	$ 0	$ 0	82.5
Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life			3 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life			21 years
Advanced Process Solutions
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment		72.3		72.3
Goodwill, pre-impairment charge					$ 95.2
Impairment charges		73		73
Molding Technology Solutions
Finite-Lived Intangible Assets [Line Items]
Reporting unit, indefinite-lived intangible asset, pre-impairment charge					125
Impairment charges		9.5		9.5
Trade names | Advanced Process Solutions
Finite-Lived Intangible Assets [Line Items]
Impairment of Intangible Assets, Indefinite-lived (excluding goodwill)		$ 0.7		$ 0.7
Reporting unit, indefinite-lived intangible asset, pre-impairment charge					$ 4.4

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Jun. 30, 2021	Sep. 30, 2020
Intangible Assets [Line Items]
Cost	$ 1,008.2	$ 1,001.1
Accumulated Amortization	(304.8)	(267.2)
Total	1,236	1,227.9
Trade names
Intangible Assets [Line Items]
Indefinite-lived assets:	227.8	226.8
Trade names
Intangible Assets [Line Items]
Cost	0.2	0.2
Accumulated Amortization	(0.2)	(0.2)
Customer relationships
Intangible Assets [Line Items]
Cost	803.4	787.6
Accumulated Amortization	(186.1)	(151.8)
Technology, including patents
Intangible Assets [Line Items]
Cost	138.4	137.6
Accumulated Amortization	(60.4)	(51)
Software
Intangible Assets [Line Items]
Cost	66.2	65.6
Accumulated Amortization	(58.1)	(54.1)
Backlog
Intangible Assets [Line Items]
Cost	0	10
Accumulated Amortization	0	(10)
Other
Intangible Assets [Line Items]
Cost	0	0.1
Accumulated Amortization	$ 0	$ (0.1)

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Goodwill (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Goodwill [Roll Forward]
Balance at the beginning of the period		$ 1,137.8
Acquisitions		19.6
Foreign currency adjustments	$ 18.4
Balance at the end of the period	1,175.8	1,175.8
Advanced Process Solutions
Goodwill [Roll Forward]
Balance at the beginning of the period		485.1
Acquisitions		0
Foreign currency adjustments	5.3
Balance at the end of the period	490.4	490.4
Molding Technology Solutions
Goodwill [Roll Forward]
Balance at the beginning of the period		644.4
Acquisitions		19.6
Foreign currency adjustments	13.1
Balance at the end of the period	677.1	677.1
Batesville
Goodwill [Roll Forward]
Balance at the beginning of the period		8.3
Acquisitions		0
Foreign currency adjustments	0
Balance at the end of the period	$ 8.3	$ 8.3

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Schedule of Impairment Charges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment				$ 72.3
Goodwill and Intangible Asset Impairment	$ 0	$ 0	$ 0	82.5
Advanced Process Solutions
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment		72.3		72.3
Goodwill and Intangible Asset Impairment		73		73
Molding Technology Solutions
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment		0		0
Goodwill and Intangible Asset Impairment		9.5		9.5
Trade names
Finite-Lived Intangible Assets [Line Items]
Intangible asset impairment				8.6
Trade names | Advanced Process Solutions
Finite-Lived Intangible Assets [Line Items]
Intangible asset impairment		0.7		0.7
Trade names | Molding Technology Solutions
Finite-Lived Intangible Assets [Line Items]
Intangible asset impairment		7.9		7.9
Technology, including patents
Finite-Lived Intangible Assets [Line Items]
Intangible asset impairment				1.6
Technology, including patents | Advanced Process Solutions
Finite-Lived Intangible Assets [Line Items]
Intangible asset impairment		0		0
Technology, including patents | Molding Technology Solutions
Finite-Lived Intangible Assets [Line Items]
Intangible asset impairment		$ 1.6		$ 1.6

Financing Agreements - Schedule

Financing Agreements - Schedule of borrowings (Details) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Total debt	$ 1,212.4	$ 1,552.6
Other	0.1	0.2
Current portion of long-term debt	0	36.3
Long-term debt	1,212.4	1,516.3
$500.0 term loan (1)
Debt Instrument [Line Items]
Total debt	0	473.7
Debt Issuance Costs, Line of Credit Arrangements, Gross	1.3
$400.0 senior unsecured notes (2)
Debt Instrument [Line Items]
Total debt	395.6	394.8
Debt Issuance Costs, Line of Credit Arrangements, Gross	4.4	5.2
$375.0 senior unsecured notes, net of discount (3)
Debt Instrument [Line Items]
Total debt	371.3	370.8
Debt Issuance Costs, Line of Credit Arrangements, Gross	3.3	3.7
$350.0 senior unsecured notes (4)
Debt Instrument [Line Items]
Total debt	345.6	0
Debt Issuance Costs, Line of Credit Arrangements, Gross	4.4
$225.0 term loan (5)
Debt Instrument [Line Items]
Total debt	0	213.4
Debt Issuance Costs, Line of Credit Arrangements, Gross		0.3
$100.0 Series A Notes (6)
Debt Instrument [Line Items]
Total debt	99.8	99.7
Debt Issuance Costs, Line of Credit Arrangements, Gross	0.2	0.3
$900.0 revolving credit facility (excluding outstanding letters of credit)
Debt Instrument [Line Items]
Total debt	$ 0	$ 0

Financing Agreements - Narrativ

Financing Agreements - Narrative (Details)	Jun. 14, 2021USD ($)	Mar. 03, 2021USD ($)	Jun. 30, 2021USD ($)	Dec. 31, 2020	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)	Sep. 30, 2020USD ($)	Jun. 16, 2020USD ($)	Sep. 30, 2019USD ($)	Dec. 15, 2014USD ($)
Debt instrument [Line Items]
Long-term Debt			$ 1,212,400,000			$ 1,212,400,000		$ 1,552,600,000
Maximum ratio of Indebtedness to EBITDA allowed				3.50
Debt Instrument, Covenant Terms, Minimum Ratio of Earnings before Interest, Taxes, Depreciation, and Amortization to Interest Expense				3
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 350,000,000		477,700,000		$ 264,900,000	477,700,000	$ 264,900,000	311,800,000		$ 399,400,000
$350.0 senior unsecured notes (4)
Debt instrument [Line Items]
Debt instrument, face amount		$ 350,000,000
Debt interest rate		3.75%
Deferred financing costs		$ 4,500,000
Debt redemption price		101.00%
Debt Issuance Costs, Line of Credit Arrangements, Gross			4,400,000			4,400,000
Long-term Debt			345,600,000			345,600,000		0
$500.0 term loan (1)
Debt instrument [Line Items]
Debt instrument, face amount			500,000,000			500,000,000
Repayments of term loans						500,000,000
Debt Issuance Costs, Line of Credit Arrangements, Gross			1,300,000			1,300,000
Long-term Debt			0			$ 0		473,700,000
Weighted average interest rates					2.59%	2.65%	3.07%
$225.0 term loan (5)
Debt instrument [Line Items]
Debt instrument, face amount			225,000,000			$ 225,000,000
Repayments of term loans						225,000,000
Debt Issuance Costs, Line of Credit Arrangements, Gross								300,000
Long-term Debt			$ 0			0		213,400,000
Weighted average interest rates			2.63%		2.46%		2.94%
$900.0 revolving credit facility (excluding outstanding letters of credit)
Debt instrument [Line Items]
Long-term Debt			$ 0			0		0
Letters of Credit Outstanding, Amount			16,500,000			16,500,000
Line of credit facility, remaining borrowing capacity			$ 883,500,000			$ 883,500,000
Weighted average interest rates					2.59%	2.28%	2.78%
Weighted average facility fee			0.17%		0.30%	0.24%	0.24%
$375.0 senior unsecured notes, net of discount (3)
Debt instrument [Line Items]
Debt instrument, face amount			$ 375,000,000			$ 375,000,000
Debt Issuance Costs, Line of Credit Arrangements, Gross			3,300,000			3,300,000		3,700,000
Long-term Debt			371,300,000			371,300,000		370,800,000
$100.0 Series A Notes (6)
Debt instrument [Line Items]
Debt instrument, face amount											$ 100,000,000
Debt interest rate											4.60%
Debt Issuance Costs, Line of Credit Arrangements, Gross			200,000			200,000		300,000
Long-term Debt			99,800,000			99,800,000		99,700,000
Other Financing Agreements
Debt instrument [Line Items]
Line of credit facility, maximum borrowing capacity			423,300,000			423,300,000		417.2
Line of credit facility, amount utilized for bank guarantees			260,200,000			260,200,000		261.4
$400.0 senior unsecured notes (2)
Debt instrument [Line Items]
Debt instrument, face amount									$ 400,000,000
Debt Issuance Costs, Line of Credit Arrangements, Gross			4,400,000			4,400,000		5,200,000
Long-term Debt			395,600,000			395,600,000		$ 394,800,000
Amendment To Credit Agreements
Debt instrument [Line Items]
Maximum ratio of Indebtedness to EBITDA allowed	3.50
Debt Instrument, Covenant Terms, Maximum Ratio of Indebtedness to Earnings before Interest, Taxes, Depreciation, and Amortization, Increase To Ratio	4
Amendment To Credit Agreements | Base Rate [Member]
Debt instrument [Line Items]
Debt Instrument, Floor Base Rate	1.00%
Amendment To Credit Agreements | London Interbank Offered Rate (LIBOR)
Debt instrument [Line Items]
Debt Instrument, Floor Base Rate	0.00%
L/G Facility Agreement Amendment
Debt instrument [Line Items]
Maximum ratio of Indebtedness to EBITDA allowed				4.25
Debt Instrument, Covenant Terms, Minimum Ratio of Earnings before Interest, Taxes, Depreciation, and Amortization to Interest Expense				3
Debt Instrument, Redemption, Period One | $350.0 senior unsecured notes (4)
Debt instrument [Line Items]
Debt redemption price		101.875%
Debt Instrument, Redemption, Period Two | $350.0 senior unsecured notes (4)
Debt instrument [Line Items]
Debt redemption price		101.25%
Debt Instrument, Redemption, Period Three | $350.0 senior unsecured notes (4)
Debt instrument [Line Items]
Debt redemption price		100.625%
Debt Instrument, Redemption, Period Four | $350.0 senior unsecured notes (4)
Debt instrument [Line Items]
Debt redemption price		100.00%
Debt Instrument, Redemption, Period Five | $350.0 senior unsecured notes (4)
Debt instrument [Line Items]
Debt redemption price		103.75%
Amount of debt available to be redeemed		40.00%
Molding Technology Solutions | Revolver [Member] | $900.0 revolving credit facility (excluding outstanding letters of credit)
Debt instrument [Line Items]
Long-term Line of Credit			$ 650,000,000			$ 650,000,000

Retirement Benefits (Details)

Retirement Benefits (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service costs	$ 0.5	$ 0.7	$ 1.5	$ 1.8
Interest costs	0.2	0.2	0.5	0.5
Expected return on plan assets	(0.2)	(0.3)	(0.6)	(0.6)
Amortization of net loss	0.7	0.5	2.2	1.8
Net periodic pension (benefit) cost	1.2	1.1	3.6	3.5
United States
Defined Benefit Plan Disclosure [Line Items]
Service costs	0.2	0.4	0.5	1.1
Interest costs	1.5	2	4.4	6
Expected return on plan assets	(2.8)	(3.3)	(8.2)	(9.7)
Amortization of net loss	0.5	1.2	1.6	3.6
Net periodic pension (benefit) cost	$ (0.6)	$ 0.3	$ (1.7)	$ 1

Retirement Benefits - Narrative

Retirement Benefits - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Defined Benefit Plan Disclosure [Line Items]
Defined Contribution Plan, Cost	$ 3.6	$ 3.7	$ 10.9	$ 10.8

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
TaxRate [Line Items]
Effective income tax rate	37.00%	53.10%	30.30%	(58.40%)
Net operating loss utilized	$ 39.6		$ 39.6
Molding Technology Solutions
TaxRate [Line Items]
Deferred tax assets, gross	5.9		5.9
Deferred tax liabilities, net	139		139
Deferred tax asset, operating loss carryforward	65.5		65.5
Deferred tax asset, valuation allowance	$ 22		$ 22

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income per common share
Net income (loss) attributable to Hillenbrand	$ 40.4	$ 24	$ 194.9	$ (53.1)
Weighted-average shares outstanding (basic - in millions) (1)	75,500,000	75,100,000	75,400,000	72,800,000
Effect of dilutive stock options and other unvested equity awards (in millions) (2)	700,000	0	500,000	0
Weighted-average shares outstanding (diluted - in millions)	76,200,000	75,100,000	75,900,000	72,800,000
Basic earnings (loss) per share	$ 0.54	$ 0.32	$ 2.59	$ (0.73)
Diluted earnings (loss) per share	$ 0.53	$ 0.32	$ 2.57	$ (0.73)
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)	100,000	2,800,000	800,000	2,900,000
Performance-based stock awards
Income per common share
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)			400,000
Molding Technology Solutions
Income per common share
Additional shares issued (in shares)			11,900,000

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Antidilutive securities excluded from computation of earnings per share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	100,000	2,800,000	800,000	2,900,000
Performance-based stock awards (maximum that can be earned)
Antidilutive securities excluded from computation of earnings per share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount			400,000

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2020
Class of Stock [Line Items]
Cash dividends paid on common stock		$ 48.4	$ 47.6
Treasury Stock
Class of Stock [Line Items]
Common stock, shares issued	0.1	0.5	(0.1)

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) - Schedule of changes in accumulated other comprehensive income (loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period			$ (102.8)
Other comprehensive income before reclassifications
Before tax amount			43.7	$ (2.6)
Tax benefit			(0.1)	0.3
After tax amount			43.6	(2.3)
Amounts reclassified from accumulated other comprehensive loss (1)			3.9	5.6
Total changes in other comprehensive income, net of tax	$ 30.4	$ 15.6	47.5	3.3
Balance at the end of the period	(55.2)		(55.2)
Pension and Postretirement
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period			(69.6)	(62.3)
Other comprehensive income before reclassifications
Before tax amount			0	0
Tax benefit			0	0
After tax amount			0	0
Amounts reclassified from accumulated other comprehensive loss (1)			2.7	3.8
Total changes in other comprehensive income, net of tax			2.7	3.8
Reclassification of certain income tax effects				(6)
Balance at the end of the period	(66.9)	(64.5)	(66.9)	(64.5)
Currency Translation
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period			(21.1)	(64.7)
Other comprehensive income before reclassifications
Before tax amount			43.4	(0.3)
Tax benefit			0	0
After tax amount			43.4	(0.3)
Amounts reclassified from accumulated other comprehensive loss (1)			0	0
Total changes in other comprehensive income, net of tax			43.4	(0.3)
Reclassification of certain income tax effects				0
Balance at the end of the period	22.3	(65)	22.3	(65)
Net Unrealized Gain (Loss) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period			(12.1)	(13.6)
Other comprehensive income before reclassifications
Before tax amount			0.4	(1.6)
Tax benefit			(0.1)	0.3
After tax amount			0.3	(1.3)
Amounts reclassified from accumulated other comprehensive loss (1)			1.2	1.8
Total changes in other comprehensive income, net of tax			1.5	0.5
Reclassification of certain income tax effects				0
Balance at the end of the period	(10.6)	(13.1)	(10.6)	(13.1)
Total Attributable to Hillenbrand, Inc.
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period			(102.8)	(140.6)
Other comprehensive income before reclassifications
Before tax amount			43.8	(1.9)
Tax benefit			(0.1)	0.3
After tax amount			43.7	(1.6)
Amounts reclassified from accumulated other comprehensive loss (1)			3.9	5.6
Total changes in other comprehensive income, net of tax			47.6	4
Reclassification of certain income tax effects				(6)
Balance at the end of the period	(55.2)	(142.6)	(55.2)	(142.6)
Noncontrolling Interests
Other comprehensive income before reclassifications
Before tax amount			(0.1)	(0.7)
Tax benefit			0	0
After tax amount			(0.1)	(0.7)
Amounts reclassified from accumulated other comprehensive loss (1)			0	0
Total changes in other comprehensive income, net of tax	$ (0.2)	$ (0.1)	$ (0.1)	$ (0.7)

Other Comprehensive Income (L_4

Other Comprehensive Income (Loss) - Schedule of reclassifications (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Affected Line in the Consolidated Statement of Operations:
Net revenue	$ 695.1	$ 607.5	$ 2,109.9	$ 1,823.3
Cost of goods sold	(469.2)	(400.2)	(1,393.9)	(1,250.5)
Other (expense) income, net	(0.4)	0.6	0.2	4.8
Tax expense	(24.4)	(28.3)	(86.1)	(17.7)
Total reclassifications for the period, net of tax			3.9	5.6
Amortization of Pension and Postretirement
Affected Line in the Consolidated Statement of Operations:
Total reclassifications for the period, net of tax			2.7	3.8
Derivative Instruments
Affected Line in the Consolidated Statement of Operations:
Total reclassifications for the period, net of tax			1.2	1.8
Reclassifications out of accumulated other comprehensive income (loss)
Affected Line in the Consolidated Statement of Operations:
Net revenue			0.2	(0.2)
Cost of goods sold	(0.3)	0.9	(0.6)	0.5
Other (expense) income, net	1.8	2.2	5.2	6.6
Total before tax	1.5	3.1	4.8	6.9
Tax expense	(0.3)	(0.5)	(0.9)	(1.3)
Total reclassifications for the period, net of tax	1.2	2.6	3.9	5.6
Reclassifications out of accumulated other comprehensive income (loss) | Net Loss Recognized
Affected Line in the Consolidated Statement of Operations:
Net revenue			0	0
Cost of goods sold	0	0	0	0
Other (expense) income, net	1.3	1.7	3.8	5.2
Total before tax	1.3	1.7	3.8	5.2
Reclassifications out of accumulated other comprehensive income (loss) | Prior Service Costs Recognized
Affected Line in the Consolidated Statement of Operations:
Net revenue			0	0
Cost of goods sold	0	0	0	0
Other (expense) income, net	0	0	(0.1)	(0.1)
Total before tax	0	0	(0.1)	(0.1)
Reclassifications out of accumulated other comprehensive income (loss) | Derivative Instruments
Affected Line in the Consolidated Statement of Operations:
Net revenue			0.2	(0.2)
Cost of goods sold	(0.3)	0.9	(0.6)	0.5
Other (expense) income, net	0.5	0.5	1.5	1.5
Total before tax	$ 0.2	$ 1.4	$ 1.1	$ 1.8

Share-Based Compensation - Sche

Share-Based Compensation - Schedule of stock-based compensation costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Compensation Related Costs [Abstract]
Share-based compensation costs	$ 4.3	$ 3.7	$ 14.7	$ 9.4
Less impact of income tax benefit	1	0.9	3.4	2.2
Share-based compensation costs, net of tax	$ 3.3	$ 2.8	$ 11.3	$ 7.2

Share-Based Compensation - Sc_2

Share-Based Compensation - Schedule of stock-based awards granted (Details)	9 Months Ended
	Jun. 30, 2021shares
Time-based stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted in period (in shares)	384,507
Performance-based stock awards (maximum that can be earned)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted in period (in shares)	366,923

Share-Based Compensation - Narr

Share-Based Compensation - Narrative (Details)	9 Months Ended
	Jun. 30, 2021$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award performance measurement period	3 years
Time-based stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grant date fair value (in dollars per share)	$ 38.80
Performance-based stock awards (maximum that can be earned)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grant date fair value (in dollars per share)	$ 44.38
Performance-based stock awards granted, number of units (in shares) | shares	214,092

Other Income, Net (Details)

Other Income, Net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Accumulated other comprehensive income (loss) [Line Items]
Net loss on divestiture	$ 0.1	$ 0	$ 65.8	$ (3)
Interest Income, Other	0.9	0.6	2.5	2.5
Foreign currency exchange (loss) gain, net	(0.2)	0.3	0.2	2.2
Other, net	(1.1)	(0.3)	(2.5)	0.1
Other (expense) income, net	$ (0.4)	$ 0.6	$ 0.2	$ 4.8

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	9 Months Ended
	Jun. 30, 2021USD ($)
General claims and lawsuits | Minimum
Commitments and Contingencies
Deductibles and self-insured retentions per occurrence or per claim	$ 0.5

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of financial assets and liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Assets:
Cash and cash equivalents	$ 476.2	$ 302.2
Investments in rabbi trust	4.7	3.9
Derivative instruments	2.6	2.6
Liabilities:
Derivative instruments	2.3	1.6
Cash flow hedging | Foreign Exchange Forward
Liabilities:
Derivative, notional amount	260.5	232.8
Level 1
Assets:
Cash and cash equivalents	476.2	302.2
Investments in rabbi trust	4.7	3.9
Derivative instruments	0	0
Liabilities:
Derivative instruments	0	0
Level 2
Assets:
Cash and cash equivalents		0
Investments in rabbi trust	0	0
Derivative instruments	2.6	2.6
Liabilities:
Derivative instruments	2.3	1.6
Level 3
Assets:
Cash and cash equivalents	0	0
Investments in rabbi trust	0	0
Derivative instruments	0	0
Liabilities:
Derivative instruments	0	0
2020 Notes
Liabilities:
Debt instruments	400	400
2020 Notes | Level 1
Liabilities:
Debt instruments	429.7	429
2020 Notes | Level 2
Liabilities:
Debt instruments	0	0
2020 Notes | Level 3
Liabilities:
Debt instruments	0	0
2019 Notes
Liabilities:
Debt instruments	374.6	374.5
2019 Notes | Level 1
Liabilities:
Debt instruments	418.2	409
2019 Notes | Level 2
Liabilities:
Debt instruments	0	0
2019 Notes | Level 3
Liabilities:
Debt instruments	0	0
2019 Notes
Liabilities:
Debt instruments	350
2019 Notes | Level 1
Liabilities:
Debt instruments	347.8
2019 Notes | Level 2
Liabilities:
Debt instruments	0
2019 Notes | Level 3
Liabilities:
Debt instruments	0
$500.0 term loan
Liabilities:
Debt instruments		475
$500.0 term loan | Level 1
Liabilities:
Debt instruments		0
$500.0 term loan | Level 2
Liabilities:
Debt instruments		475
$500.0 term loan | Level 3
Liabilities:
Debt instruments		0
$225.0 term loan
Liabilities:
Debt instruments		213.7
$225.0 term loan | Level 1
Liabilities:
Debt instruments		0
$225.0 term loan | Level 2
Liabilities:
Debt instruments		213.7
$225.0 term loan | Level 3
Liabilities:
Debt instruments		0
Series A Notes
Liabilities:
Debt instruments	100	100
Series A Notes | Level 1
Liabilities:
Debt instruments	0	0
Series A Notes | Level 2
Liabilities:
Debt instruments	105.7	105.3
Series A Notes | Level 3
Liabilities:
Debt instruments	$ 0	$ 0

Segment and Geographical Info_3

Segment and Geographical Information - Schedule of net revenue and assets by segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020
Segment and Geographical Information
Total assets	$ 4,037.4		$ 4,037.4		$ 3,987.4
Property, plant, and equipment, net	440.7		440.7		468.6
Net revenue	695.1	$ 607.5	2,109.9	$ 1,823.3
United States
Segment and Geographical Information
Property, plant, and equipment, net	165.8		165.8		182.4
Net revenue	301.3	298.5	973.1	880.2
GERMANY
Segment and Geographical Information
Property, plant, and equipment, net	113.4		113.4		110.4
Net revenue	35.2	33.5	101.9	114.7
CHINA
Segment and Geographical Information
Property, plant, and equipment, net	52.5		52.5		54.2
Net revenue	135.8	98.6	362.6	225.9
INDIA
Segment and Geographical Information
Net revenue	39	17.7	127.5	85.8
All other countries
Segment and Geographical Information
Property, plant, and equipment, net	109		109		121.6
Net revenue	183.8	159.2	544.8	516.7
Operating segments
Segment and Geographical Information
Net revenue	695.1	607.5	2,109.9	1,823.3
Corporate
Segment and Geographical Information
Adjusted EBITDA (1)	(13.9)	(11.1)	(41.9)	(30.9)
Total assets	52.5		52.5		63.2
Advanced Process Solutions
Segment and Geographical Information
Net revenue	313.4	281.3	905.5	899
Advanced Process Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	61.1	57.6	165.3	166.6
Total assets	1,664.3		1,664.3		1,666.5
Molding Technology Solutions
Segment and Geographical Information
Net revenue	243.8	186.3	735.7	518.6
Molding Technology Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	49.2	38.1	148.4	96.4
Total assets	2,091.7		2,091.7		2,032.4
Batesville
Segment and Geographical Information
Net revenue	137.9	139.9	468.7	405.7
Batesville | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	29.8	$ 36.4	126.7	$ 91.4
Total assets	$ 228.9		$ 228.9		$ 225.3

Segment and Geographical Info_4

Segment and Geographical Information - Schedule of reconciliation of segment (Details 2) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Segment and Geographical Information
Interest income	$ (0.9)	$ (0.6)	$ (2.5)	$ (2.5)
Interest expense	19	19.7	59.7	55.3
Income tax expense	24.4	28.3	86.1	17.7
Depreciation and amortization	28.7	33.9	86.3	98.4
Impairment charges	0	0	0	82.5
Business acquisition, development, and integration costs	6.4	5.5	25.2	67.3
Inventory step-up	6.5	3.6	10.2	6.7
Net loss on divestiture	(0.1)	0	(65.8)	3
Other	0.7	2	1.1	2.4
Business Combination, Inventory Step Up Costs	0	3.6	0	40.7
Consolidated net income (loss)	41.5	25	198.2	(48)
Corporate
Segment and Geographical Information
Adjusted EBITDA (1)	(13.9)	(11.1)	(41.9)	(30.9)
Advanced Process Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	61.1	57.6	165.3	166.6
Molding Technology Solutions
Segment and Geographical Information
Impairment charges		9.5		9.5
Molding Technology Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	49.2	38.1	148.4	96.4
Batesville | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	$ 29.8	$ 36.4	$ 126.7	$ 91.4

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Restructuring and Related Cost
Restructuring charges	$ 8,800,000	$ 3,400,000	$ 14,300,000	$ 7,800,000
Inventory step-up	6,500,000	3,600,000	10,200,000	6,700,000
Restructuring reserve, current	7,400,000		7,400,000
Restructuring liability	3,800,000
Cost of Sales
Restructuring and Related Cost
Restructuring charges	3,800,000
Minimum
Restructuring and Related Cost
Inventory step-up	4,000,000
Severance costs	13,000,000
Maximum
Restructuring and Related Cost
Inventory step-up	6,000,000
Severance costs	14,000,000
Corporate
Restructuring and Related Cost
Restructuring charges	100,000	400,000	800,000	1,400,000
Advanced Process Solutions
Restructuring and Related Cost
Restructuring charges	7,200,000	2,100,000	9,700,000	4,000,000
Molding Technology Solutions
Restructuring and Related Cost
Restructuring charges	1,300,000	900,000	3,300,000	1,900,000
Batesville
Restructuring and Related Cost
Restructuring charges	200,000	0	500,000	500,000
Operating expense
Restructuring and Related Cost
Restructuring charges	2,200,000	2,500,000	5,600,000	6,300,000
Operating expense | Corporate
Restructuring and Related Cost
Restructuring charges	100,000	400,000	800,000	1,400,000
Operating expense | Advanced Process Solutions
Restructuring and Related Cost
Restructuring charges	1,900,000	1,900,000	3,600,000	3,100,000
Operating expense | Molding Technology Solutions
Restructuring and Related Cost
Restructuring charges	0	100,000	700,000	1,300,000
Operating expense | Batesville
Restructuring and Related Cost
Restructuring charges	200,000	100,000	500,000	500,000
Cost of goods, segment | Corporate
Restructuring and Related Cost
Restructuring charges	0	0	0	0
Cost of goods, segment | Advanced Process Solutions
Restructuring and Related Cost
Restructuring charges	5,300,000	200,000	6,100,000	900,000
Cost of goods, segment | Molding Technology Solutions
Restructuring and Related Cost
Restructuring charges	1,300,000	800,000	2,600,000	600,000
Cost of goods, segment | Batesville
Restructuring and Related Cost
Restructuring charges	0	(100,000)	0	0
Cost of Goods and Service Benchmark [Member]
Restructuring and Related Cost
Restructuring charges	$ 6,600,000	$ 900,000	$ 8,700,000	$ 1,500,000

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event	1 Months Ended
	Aug. 04, 2021USD ($)shares
Subsequent Event [Line Items]
Common stock acquired (in shares) | shares	1,289,000
Purchase price of common stock | $	$ 56,600,000